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Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic herpesvirus associated
with various AIDS-related malignancies. Like other herpesviruses, multiple processes
required for KSHV lytic replication, including viral transcription, viral DNA synthesis and
capsid assembly occur in virus-induced intranuclear structures, termed replication and tran-
scription compartments (RTCs). Here we utilised a novel methodology, combining subcellu-
lar fractionation and quantitative proteomics, to identify cellular proteins which are recruited
to KSHV-induced RTCs and thus play a key role in KSHV lytic replication. We show that
several isoforms of the HSP70 chaperone family, Hsc70 and iHsp70, are redistributed from
the cytoplasm into the nucleus coinciding with the initial formation of KSHV-induced RTCs.
We demonstrate that nuclear chaperone foci are dynamic, initially forming adjacent to
newly formed KSHV RTCs, however during later time points the chaperones move within
KSHV RTCs and completely co-localise with actively replicating viral DNA. The functional
significance of Hsp70 isoforms recruitment into KSHV RTCs was also examined using the
specific Hsp70 isoform small molecule inhibitor, VER-155008. Intriguingly, results highlight
an essential role of Hsp70 isoforms in the KSHV replication cycle independent of protein
stability and maturation. Notably, inhibition of Hsp70 isoforms precluded KSHV RTC forma-
tion and RNA polymerase II (RNAPII) relocalisation to the viral genome leading to the abol-
ishment of global KSHV transcription and subsequent viral protein synthesis and DNA
replication. These new findings have revealed novel mechanisms that regulate KSHV lytic
replication and highlight the potential of HSP70 inhibitors as novel antiviral agents.
Author Summary
Molecular chaperones from the HSP70 and HSP90 families have important roles in cell
survival. Recent evidence has also implicated their functioning in a variety of diseases,
including cancer. As such they have been identified as emerging drug targets. Kaposi’s
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sarcoma-associated herpesvirus (KSHV) is an oncogenic herpesvirus which, like other her-
pesviruses, lytically replicates in virus-induced structures within the nucleus, termed repli-
cation and transcription compartments (RTCs). Here we developed a novel proteomic
approach enhanced by subcellular fractionation to study the cellular protein composition
of KSHV-induced RTCs. Results revealed that the constitutively expressed Hsc70 and the
stress-inducible iHsp70 chaperones were significantly increased in the KSHV-induced
RTCs. Importantly, inhibition of the ATPase function of these chaperones led to a marked
reduction in KSHV RTCs formation and KSHV lytic replication. Notably, these results
highlight the therapeutic potential ofHSP70 inhibitors for the treatment of KSHV-related
diseases, such as Kaposi’s sarcoma.
Introduction
Molecular chaperones represent a large group of proteins that are essential for maintaining cel-
lular homeostasis and survival. As such, the roles of these proteins are numerous; facilitating
correct protein folding or unfolding, assembly or disassembly of multimeric protein complexes,
participating in translocation of proteins and vesicles into organelles, stabilising a wide range
of signalling molecules and preventing aggregation of non-native proteins (reviewed in [1, 2]).
Heat shock proteins (HSP) are classified according to their molecular weight into several fami-
lies:HSP40,HSP60,HSP70,HSP90, HSP100, HSP110 and the small HSP (less than 34 kDa)[3].
The functional importance of the HSP70 and HSP90 families of molecular chaperones is exem-
plified by their emerging implications in a variety of diseases, including cancer [4, 5], neurode-
generation [6] or viral infection [7, 8]. As such they have gained significant interest recently as
potential drug targets.
Eukaryotes have multiple genes encoding for chaperones of theHSP70 family, which are
amongst the most conserved proteins in evolution [9–11]. The major Hsp70 isoforms are the
constitutively expressed Hsc70, the stress-inducible Hsp70 (iHsp70), the endoplasmic reticu-
lum resident (Grp78) and the mitochondrial form (Grp75). All Hsp70 isoforms have an N-ter-
minal domain which harbours a highly conserved ATPase and a C-terminal substrate binding
domain [1]. Hsp90 isoforms which comprise the inducible and constitutively-expressed iso-
forms (Hsp90α and Hsp90β respectively), the ER resident (Grp74) and the mitochondrial
form (TRAP1), also possess a N-terminal ATP binding domain, although this has no similarity
to the ATP-binding domain found in the chaperones of theHSP70 family [5]. The presence of
ATPase pockets in both families of chaperones makes these proteins desirable targets for small
molecule inhibitors [12, 13]. The therapeutic potential of these compounds is especially evident
for severalHSP90 inhibitors, having already reached phase II and III clinical trials [14, 15]. Tar-
geting of Hsp70 isoforms has been more challenging [12], but recently specific inhibitors have
also undergone clinical trials [16, 17]. Importantly, the development of highly specific inhibi-
tors for Hsp70 isoforms may have potential for the treatment of a diverse group of viruses as
the functional importance of Hsp70 isoforms in the life cycle of numerous viruses has been
highlighted over the past few years [8]. Distinct Hsp70 isoforms are usurped to aid in many
stages of viral replication as varied as viral entry, uncoating, transcription, envelope protein
maturation, morphogenesis or DNA replication [8]. Therefore, the importance of these chaper-
ones in the life cycle of such a wide range of viruses suggests the potential of these proteins as
targets for broad-spectrum antivirals.
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causative agent of several AIDS-
associated malignancies, including Kaposi’s sarcoma (KS), a highly vascular tumour of
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endothelial lymphatic origin. Similar to other herpesviruses, KSHV exists in two distinct life
cycles, latent persistence or lytic replication phases. However, unlike other human oncogenic
viruses where the latent cycle is predominantly responsible for tumorigenesis, both the latent
and lytic replication phases are essential for KSHV tumorigenicity in KS [18, 19]. During
latency, which is established in B cells and in the tumour setting, viral gene expression is highly
restricted, only involving expression of the latency-associated nuclear antigen (LANA), the
viral FLICE inhibitory protein, viral cyclin, kaposins and several virally-encoded miRNAs [20].
However, upon reactivation, the virus enters the lytic reactivation cycle leading to expression
of more than 80 protein-coding sequences and replication of viral genomes [21] in a highly
orchestrated sequential manner. Infectious virions can then spread to endothelial cells where
tumours develop. Moreover in KS lesions, where most infected cells harbour the virus in a
latent state, a small proportion of cells undergo lytic replication which leads to secretion of lyti-
cally-expressed angiogenic, inflammatory and proliferative factors that act in a paracrine man-
ner on latently-infected cells enhancing tumourigenesis [20]. Furthermore, lytic replication
enhances genomic instability [22] and also sustains the population of latently-infected cells
that would otherwise be reduced due to the poor persistence of KSHV episomes during cell
division [23]. Therefore, inhibiting KSHV lytic replication may lead to a novel therapeutic
intervention for the treatment of KSHV-associated diseases.
KSHV initiates lytic replication upon transcription of the ORF50/RTA gene which encodes
the conserved lytic master switch RTA protein. RTA is then able to trigger the entire lytic gene
expression cascade in KSHV and other γ-2 herpesviruses [24, 25]. KSHV transcription, DNA
replication and packaging, and capsid assembly all occur in virus-induced nuclear structures,
termed replication and transcription compartments (RTCs) [26]. Early in herpesvirus infec-
tion, viral transcription of early genes and viral DNA replication takes place in small RTCs
[27], that generally concentrate at the nuclear periphery [28–30]. As infection progresses, the
nuclear architecture undergoes a striking re-organization to facilitate viral replication. Small
RTCs coalesce into single large globular or kidney-shaped structures that ultimately fill most of
the nuclear space compressing and marginalizing the cellular chromatin to the nuclear periph-
ery [28, 29]. These large RTCs support late viral gene expression, viral DNA synthesis and cap-
sid assembly [27]. Previous efforts to identify the protein composition, both viral and cellular,
of herpesvirus RTCs have been carried out using immunoprecipitation-based assays, identify-
ing proteins that associate either with the KSHV lytic origin of DNA replication (ori-Lyt) [31]
or with known HSV-1 viral proteins which accumulate in RTCs [32]. However, these immuno-
precipitation-based approaches restrict the number of proteins identified and are not quantita-
tive, thus a more quantifiable and high-throughput method is highly desirable.
In recent years, the use of shotgun proteomics has proved an invaluable tool to investigate
global analysis of protein composition, allowing the elucidation of new aspects of viral biology
[33]. An enhanced approach to this methodology is the combined use of subcellular fraction-
ation with shotgun proteomics [34]. This allows the identification of cellular proteins that can
easily be masked by more abundant proteins in studies which interrogate the global proteome
using whole cell lysates or large cellular regions (e.g. nuclear or cytoplasmic). Therefore, we
have utilised a novel quantitative proteomic approach to identify cellular proteins which are
either recruited to or present at significant levels in KSHV-induced RTCs and thus play a key
role during KSHV lytic replication. Herein, we have utilised subcellular fractionation coupled
to stable isotope labelling by amino acids in cell culture (SILAC)-based quantitative proteomics
followed by liquid chromatography (LC)-tandem mass spectrometry (MS/MS). We uniquely
isolated the nuclear envelope (NE) region from unreactivated (harbouring latent virus) and
KSHV-reactivated (harbouring lytic virus) cells using a recently developed method [35] and
notably demonstrate the enrichment of purified RTCs. A rationale of this approach is that the
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NE cannot be purified completely due to its multiple subcellular connections. The outer
nuclear membrane is continuous with the endoplasmic reticulum and interacts with the cyto-
skeleton [36, 37] while the inner nuclear membrane binds to host chromatin [38–40]. Thus, we
took advantage of its incomplete purity so that we could isolate not only the NE and embedded
nuclear pore complexes, but also components found in the NE neighbourhood, such as RTCs.
Utilising this novel approach we demonstrate that cellular chaperones from the HSP70 family
(Hsc70 and iHsp70) are significantly increased in the NE-associated RTCs of reactivated cells.
Functional dissection further demonstrates that these chaperones were specifically recruited to
the periphery of incipient RTCs coinciding in time with their formation. When actively repli-
cated viral DNA was synthesised the chaperones were recruited within RTCs. Strikingly, inhi-
bition of Hsp70 isoforms precluded RTC formation, curtailed chaperone redistribution within
RTCs and RNAPII recruitment to viral promoters. Importantly, abrogation of lytic replication
occurred without affecting cell viability, suggesting that the cellular housekeeping functions
carried out by these chaperones were not compromised. As such, HSP70 inhibitors may pro-
vide a novel therapeutic approach for the treatment of KSHV-associated malignancies, in par-
ticular it would be interesting to determine the efficacy of combining the potential of inhibiting
lytic replication using HSP70 inhibitors with the previous reported effect of HSP90 inhibitors
to eradicate latent KSHV reservoirs [41].
Results
The cellular chaperones Hsc70, iHsp70 and Grp78 were enhanced in
the NE-associated RTCs of reactivated HEK-293T rKSHV.219 cells
To investigate differential proteome changes which occur during KSHV lytic replication in
NE-associated RTCs, we utilised the HEK-293T cell line containing a latent recombinant
KSHV virus (rKSHV.219) [42]. This cell line can be reactivated into a full lytic replication cycle
via chemical induction. Unreactivated cells were grown in isotopically labelled media (R6K4),
while cells to be reactivated were grown in label-free media (R0K0). After isotopic labelling was
complete, cells were reactivated for 48 h and nuclear envelopes (NEs) were then successfully
purified using a recently described method [35], with minor modifications. Western blot analy-
sis of the NE preparations demonstrated an enrichment of nucleoporins (Nups), lamins and
histones and a loss of cytoplasmic (GAPDH) and nucleolar (B-23, C-23) proteins compared
with whole cell (WC) lysates (Fig 1). The essential KSHV mRNA processing protein, ORF57
[43], and viral RTA served as markers for lytic viral replication and RTC enrichment, as both
of these proteins are known to be recruited to KSHV RTCs [31, 44]. The monoclonal antibody
(Mab414), which recognises the phenylalanine-glycine (FG)-repeat motif present in numerous
Nups, and the polyclonal antibodies against Nup160 and lamin B1 were used to assess enrich-
ment of the NE region. NE preparations showed a higher number of Nups (closed arrows)
than their respective WC preparations; although some Nups were lost following 0.3 M salt
wash (open arrow). Following LC-MS/MS analysis and using a minimum of three unique pep-
tides assigned to a single protein, most proteins (1072) remained unchanged in their abun-
dance irrespectively of KSHV lytic infection and only five proteins had a significant reduction
(ratio cut-off<0.5) in NEs of reactivated cells. In contrast, 216 proteins showed a significant
increase (ratio cut-off>1.9) during lytic replication. Importantly, multiple cellular proteins
that are known or expected to localize within herpesvirus RTCs; such as those associated with
KSHV ori-Lyt, the HCMV transactivator IE2-p86 protein or the herpes simplex virus-1 (HSV-
1) ICP8 protein were found significantly increased in the NE regions of reactivated cells using
the less stringent ratio cut-off of 1.5 (S1 Table). Some of these cellular proteins included
CSNK2A1 [45], BLM [32], topoisomerases I and II [31, 46, 47] and DEAD box helicases DDX5
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[32] and DDX17 [45]. Thus, LC-MS/MS results confirmed the correct isolation of the NE
region and accompanying RTCs. Importantly, many of the 216 identified proteins most likely
represent novel cellular proteins hijacked by KSHV, not only due to the subcellular fraction-
ation carried out but also to the uncommon use of urea for protein extraction before LC-MS/
MS. All proteins identified by LC-MS/MS can be seen on S1 Dataset. Bioinformatical analysis
revealed several upregulated pathways (ratio cut-off>1.9) in reactivated cells (S2 Table). Of
particular interest was an upregulated pathway which related to protein folding. This included
several Hsp70 isoforms and their associated co-chaperones from theHSP40 (DNAJ) family
(Table 1).
Notably, the constitutively expressed chaperone Hsc70 presented a 4.1-fold increase with 41
unique peptides assigned. This protein had the highest fold increase associated with the most
unique peptide number of all the proteins identified by LC-MS/MS. This could be due to
increased Hsc70 expression or to the redistribution of Hsc70 from the cytoplasm into the NE
region during KSHV lytic replication. Therefore, due to the vital importance of Hsp70 isoforms
in the replication cycle of a wide range of viral families, we focussed our studies herein on the
roles of the three main Hsp70 isoforms (Hsc70, iHsp70 and Grp78) during KSHV lytic
replication.
Hsc70 and iHsp70 are redistributed from the cytoplasm to both the
periphery and within KSHV-induced RTCs
To verify the enrichment of Hsc70 in the NE-associated RTCs of reactivated cells detected by
our quantitative proteomic approach, indirect immunofluorescence was used to label endoge-
nous Hsc70 protein in TREx BCBL1-RTA cells, a KSHV latently infected B-lymphocyte cell
line containing a Myc-tagged version of viral RTA under the control of a doxycycline-inducible
promoter [48]. Hsc70 protein was equally distributed between the cytoplasm and nucleus of
unreactivated cells in a fine punctuate pattern (Fig 2Ai). Similar Hsc70 localization was seen
during early lytic replication (12 h reactivation), when RTA protein was diffuse in the nucleus,
Fig 1. Successful enrichment of the nuclear envelope region and associated KSHV RTCs in HEK-293T
rKSHV.219 cells. Successful enrichment of NE regions in unreactivated (-) and reactivated for 48 h (+) HEK-
293T rKSHV.219 cells was demonstrated byWestern blotting. Equal amounts of total protein extracted from
whole cell (WC) and nuclear envelope (NE) fractions were used. The monoclonal antibody Mab414
specifically recognises the phenylalanine-glycine (FG)-repeat motif present in numerous nucleoporins
(Nups). Closed arrows point to Nups that were only detected by MAb414 after NE enrichment. Open arrow
points to a nucleoporin lost during NE enrichment. Several FG Nups, together with Nup160, histone H3 and
lamin B1 were all markedly enriched in the NE fractions compared with WC fractions. The nucleolar proteins
B-23 and C-23 and the cytoplasmic GAPDH protein were all decreased in NEs fractions indicating correct
subcellular fractionation. The viral RTC-associated ORF57 and RTA proteins were used to monitor lytic
reactivation and assess RTC enrichment. ORF57 antibody detected both full length ORF57 protein
(FL-ORF57) and the caspase-7-cleaved ORF57 (CL-ORF57).
doi:10.1371/journal.ppat.1005274.g001
Table 1. SILAC results from NE fractions highlighted chaperones from the HSP70 family and their associated co-chaperones
Protein UniProt number Ratio Reactivated/ Unreactivated Unique peptides
Hsp70-1/Hsp70-2 (iHsp70) P08107 6.6 1
Hsc70 P11142 4.1 41
Grp78 (BiP) P11021 3.64 16
DNAJA1 P31689 4.158 12
DNAJB1 P25685 21.831 7
DNAJB6 B4DVN1 5.338 5
doi:10.1371/journal.ppat.1005274.t001
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Fig 2. Hsc70 was redistributed from the cytoplasm to both the periphery and within KSHV-induced RTCs. (A) Unreactivated TREx BCBL1-RTA cells
exhibited endogenous Hsc70 protein equally distributed between the cytoplasm and the nucleus (i). The same Hsc70 location was seen at 12 h reactivation
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prior to RTC formation (Fig 2Aii). In contrast, at later reactivation time points (20 h), in
which RTA was organised into small viral RTCs peripherally located in the nucleus, numerous
nuclear Hsc70 foci that were predominantly adjacent to RTCs were observed (Fig 2Aiii). Dur-
ing late reactivation time points (26 h), cellular chromatin was marginalised to the nuclear
periphery (Fig 2Aiv, nucleus highlighted in yellow) and larger Hsc70 foci avidly accumulated
within these fully-developed RTCs (Fig 2Aiv). Reduced levels of cytoplasmic Hsc70 were also
observed at this time point (Fig 2Aiv arrows), suggesting that Hsc70 is redistributed from the
cytoplasm to the nucleus during KSHV lytic replication. This is further supported by the fact
that fractionation of TREx BCBL1-RTA cells into nuclear (N) and cytoplasmic (C) fractions
displayed an enrichment of Hsc70 in the nuclei of reactivated cells which occurred without a
noticeable increase in Hsc70 protein levels in whole cell (WC) lysates (Fig 2B). Due to the
observed redistribution of Hsc70 to KSHV RTCs, further co-localization studies between
Hsc70 and the sites of viral DNA replication were performed in TREx BCBL1-RTA cells. Here,
cells were triple-labelled with Click-iT EdU Alexa Fluor 647 and antibodies specific for RTA
and Hsc70. In unreactivated cells, newly synthesized cellular DNA during mid-S-phase (EdU
incorporated) occurred mainly at the nuclear periphery as previously observed in other cell
types [49, 50] (Fig 2Ci). During early reactivation, Hsc70 was adjacent to RTA which was pres-
ent in small viral RTCs containing actively replicating viral DNA (Fig 2Cii arrow). At this
stage, a proportion of Hsc70 also co-localised with RTA (Fig 2Cii’). During late reactivation,
when cellular chromatin was marginalised, much larger RTCs were visible and newly synthe-
sized cellular DNA was not apparent, here Hsc70 completely co-localised with newly synthe-
sized viral DNA and RTA (Fig 2Ciii and 2Ciii’).
The location of the other two main Hsp70 isoforms (iHsp70 and Grp78) during KSHV lytic
replication was also investigated by indirect immunofluorescence microscopy. iHsp70 was
cytoplasmic in unreactivated TREx BCBL1-RTA cells (S1Ai Fig), in contrast, an increase in
nuclear iHsp70 labelling was observed in reactivated cells, which displayed similar chaperone
foci as those seen during early reactivation for Hsc70 (S1Aii Fig). Occasionally, cells displayed
RTCs completely filled by iHsp70 (S1Aiii and S1Aiv Fig, asterisks). Large iHsp70 foci posi-
tioned adjacent to RTCs were also seen in reactivated cells at later time points (S1Aiv Fig
arrows). Co-localisation of iHsp70 with actively replicating viral DNA was also observed dur-
ing late reactivation (S1B Fig). Hsc70 and iHsp70 nuclear foci appeared at the same time as
KSHV RTCs were assembled, suggesting that these chaperones could be involved in RTC
assembly. Additionally, complete co-localization of Hsc70 and iHsp70 with viral DNA indi-
cated that these chaperones could also participate in viral DNA replication and/or capsid
assembly. In contrast, the endoplasmic reticulum (ER) Hsp70 isoform, Grp78, was not redis-
tributed in reactivated TREx BCBL1-RTA cells (S2 Fig), consistent with its ER retention signal
[51]. Nevertheless, reactivated cells seemed to accumulate larger amounts of Grp78 in the ER.
To confirm these results, immunoflourescence studies were also performed using HEK-293T
prior to RTC formation, when RTA was diffuse in the nucleus (ii). At 20 h reactivation viral RTA was assembled into incipient RTCs. Hsc70 was not detected
in the cytoplasm and instead numerous nuclear foci that were positioned predominantly adjacent to RTCs were seen (iii). At later reactivation times very large
Hsc70 foci were completely recruited within RTCs. Hsc70 cytoplasmic depletion is indicated (iv arrows). Nucleus highlighted in yellow shows a typical KSHV
fully developed-RTC with cellular chromatin marginalised to the nuclear periphery. (B) Unreactivated (-) or reactivated for 26 h (+) TREx BCBL1-RTA cells
were fractionated into whole cell (WC), cytoplasmic (C) and nuclear (N) fractions. Equal amounts of total protein from each fraction were analysed by
Western blotting. Nuclear fractions were characterised by enrichment of lamin B1 and absence of cytoplasmic GAPDH, while cytoplasmic fractions showed
the inverse profile. A small decrease in cytoplasmic Hsc70 which correlated with a small increase in nuclear Hsc70 was detected in reactivated cells, further
supporting that Hsc70 was redistributed from the cytoplasm to the nucleus. (C) TREx BCBL1-RTA cells remained unreactivated (i) or reactivated for 24 h (ii-
iii’) followed by triple-labelling with antibodies specific for RTA and Hsc70 and Click-iT EdU Alexa Fluor 647, the latter allowed visualization of newly
synthesized DNA. During early reactivation, a proportion of Hsc70 protein was adjacent to small viral RTCs. Arrow points to a small KSHV RTC filled with
viral DNA (ii). Hsc70 also partially co-localised with viral DNA (ii) and RTA (ii’) in small RTCs. During later reactivation times, Hsc70 completely moved within
fully-developed RTCs strongly co-localising with viral DNA (iii) and RTA (iii’).
doi:10.1371/journal.ppat.1005274.g002
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rKSHV.219 cells, in which the presence of the recombinant virus is tracked by expression of
the green fluorescent protein (GFP) from the EF-1alpha promoter and lytic reactivation levels
are monitored by expression of the red fluorescent protein (RFP) from the KSHV lytic non-
coding polyadenylated nuclear (PAN) RNA promoter. Unreactivated cells displayed cyto-
plasmic iHsp70 and Hsc70 labelling, whereas ~ 40% of reactivated cells (24 h reactivation)
revealed nuclear iHsp70 and Hsc70 accumulations that appeared to assemble within small
RTCs (S3A Fig arrows and S3B Fig arrows respectively). The incomplete redistribution of
iHsp70 and Hsc70 foci into RTCs was likely due to a more asynchronous progression through
the lytic cycle in induced cells by TPA and sodium n-butyrate than in doxycycline-induced
TREx BCBL1-RTA cells. Similarly to TREx BCBL1-RTA cells, Grp78 was not redistributed in
HEK-293T rKSHV.219 cells, although larger amounts appeared to accumulate in the ER of
reactivated cells (S3C Fig), in agreement with the significantly increased amounts of Grp78
detected in the NE region of these cells (Table 1). These results clearly demonstrate that KSHV
specifically redistributes the molecular chaperones, Hsc70 and iHsp70, from the cytoplasm to
the nucleus, in contrast to Grp78, which coincides with the initial formation of KSHV RTCs.
Treatment with the small molecule inhibitor VER-155008 abrogated viral
protein synthesis at non-cytotoxic concentrations
Members of the HSP70 chaperone family possess an N-terminal nucleotide binding domain
with ATPase activity which is essential for their function. To examine the implications of
Hsc70 and iHsp70 redistribution into KSHV RTCs, a small molecule inhibitor, VER-155008,
(a dibenzyl-8-aminoadenosine analog) was utilised. This is the only inhibitor that has been
demonstrated to specifically target the highly homologous ATPase pocket present in the three
main human Hsp70 isoforms [12, 13, 52, 53], which is highly divergent structurally from the
ATPase pocket found in chaperones of the HSP90 family [12, 54]. As such, VER-155008 func-
tions as an ATP mimetic that specifically inhibits the ATPase activity of members of the
HSP70 family. Initially, cytotoxicity of this compound was assessed in unreactivated TREx
BCBL1-RTA cells. Following 24 h inhibitor exposure, using a non-radioactive MTS assay,
which quantitatively assesses cell proliferation, a drastic reduction in cell metabolic activity
was seen for inhibitor concentrations higher than 6 μM (S4 Fig), thus concentrations ranging
from 1 to 4 μMwere used for further cytotoxicity characterization (Fig 3Ai). The inhibitor trig-
gered apoptosis in a dose-dependent manner as demonstrated by the caspase 3-mediated cleav-
age of full length poly [ADP-ribose] polymerase (FL-PARP1) protein into cleaved PARP1
(CL-PARP1) (Fig 3Aii). Small amounts of CL-PARP1 were seen at 1 μM and 2 μMwith a sig-
nificant increase of this form after 3 μM. These results were confirmed with ApoTox-Glo Tri-
plex Assay by quantitatively measuring viability, cytotoxicity and activation of effector
caspases-3/7 in the same sample well after 24 h inhibitor treatment. A dose-dependent decrease
in viability was evident from 2 μM to 50 μMwhile cytotoxicity and activation of caspases-3/7
were only considerably increased at concentrations higher than 3 μM (Fig 3B).
Next, TREx BCBL1-RTA cells were reactivated for 24 h in the presence of drug vehicle
DMSO (0.1%) or a range of increasing inhibitor concentrations. Cells treated with the inhibitor
at non-cytotoxic concentrations (1 to 2.5 μM) revealed a drastic reduction in the levels of early
ORF57 and late minor capsid (mCapsid) proteins. A moderate reduction in the immediate-
early RTA protein was also seen (Fig 3C). Of note, when detecting the fusion protein RTA-
Myc, which expression is not from the KSHV genome, with anti-Myc antibody, the decrease in
RTA-Myc was not as dramatic as that seen for viral RTA, suggesting that the decrease in viral
proteins was not due to a general cytotoxic effect of the inhibitor on the cells, and that viral, but
not cellular proteins were specifically affected. As an additional cellular control, protein levels
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Fig 3. VER-155008 abrogated viral protein synthesis pre-translationally in TREx BCBL1-RTA cells. (A) Cytotoxicity of VER-155008 was assessed in
unreactivated cells exposed to increasing inhibitor concentrations for 24 h. (i) Cell metabolic activity was reduced in a dose-dependent manner as quantified
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of the large subunit of RNAPII, which has a half-life of 12–16 h [55], was assessed with anti-
bodies specific for the different phosphorylated forms of RNAPII. Protein levels of these forms
were not significantly changed in the presence of the inhibitor, nor were those of Hsc70 or
Hsp90 proteins. Importantly, in the presence of VER-155008, iHsp70 levels were not upregu-
lated. iHsp70 upregulation is a universal hallmark of Hsp90 inhibition not only in vitro [56]
but also in clinical trials [57], pointing to selectivity for Hsp70 isoforms by VER-155008.
Hsp90 and Hsp70 chaperone machineries have been reported to be crucial for the stability
and/or maturation of multiple viral proteins [7, 41, 58–62]. Therefore to ascertain whether
Hsp70 isoforms could stabilise the essential KSHV lytic proteins RTA and ORF57, TREx
BCBL1-RTA cells were reactivated for 24 h to allow sufficient viral protein expression followed
by addition of DMSO control or VER-155008 in conjunction with cycloheximide (CHX) at
50 μg/ml to block de novo protein synthesis. Protein lysates were then collected at different
times after addition of CHX. The half-life of RTA and ORF57 proteins from inhibitor-treated
cells were not altered compared with DMSO-treated cells (Fig 3D). These results indicate that
the observed decrease in viral protein synthesis was prior to translation and that neither viral
RTA nor ORF57 protein were client proteins of the Hsp70 isoforms. As such, this highlights a
potentially novel role of Hsp70 isoforms in the KSHV replication cycle independent of viral
protein stability and maturation.
To further corroborate these results, experiments were also repeated in HEK-293T
rKSHV.219 cells. Again, cell metabolic activity, PARP1 cleavage, viability, cytotoxicity and acti-
vation of caspases-3/7 in unreactivated cells were all assessed at a range of increasing inhibitor
concentrations (Fig 4A and 4B). On this occasion, the inhibitor did not trigger apoptosis (Fig
4Aii and 4B) but it caused a pronounced cell cycle arrest at 24 h exposure at concentrations
of 20 μM demonstrated by a reduced number of metabolically active cells that exhibited no
increased cytotoxicity [63] (Fig 4B). It is known that the apoptotic potential of VER-155008 is
cell line-dependent and that VER-155008 can cause cell cycle arrest in human colon, breast
and lung tumour cell lines [54, 64]. HEK-293T rKSHV.219 cells were also reactivated for 24 h
in the presence of drug vehicle DMSO (0.1%) or increasing inhibitor concentrations. Endoge-
nous RTA, ORF57 and mCapsid protein levels were moderately reduced in cells treated at an
inhibitor concentration of 10 μM and severely reduced at 40 μMwhile cellular proteins remain
unaffected (Fig 4C). These were relatively high inhibitor concentrations compared with TREx
BCBL1-RTA cells; nonetheless a concentration of 40 μMhas been shown before to be necessary
for inhibition of Hsp70 isoforms in human carcinoma cell lines [54]. As previously seen in
TREx BCBL1-RTA cells, when blocking de novo protein synthesis with CHX at 100 μg/ml in
HEK-293T rKSHV.219 cells, the half-life of RTA and ORF57 proteins were not reduced even
in the presence of VER-155008 at 50 μM (Fig 4D). This supports the findings seen in TREx
BCBL1-RTA cells, suggesting that the decrease in viral protein production was due to a pre-
translation event.
using an MTS assay. (ii) A dose-dependent cleavage of full length (FL) PARP1 protein into cleaved (CL) PARP1 was observed in the presence of VER-
155008. (B) Unreactivated cells were exposed for 24 h to increasing inhibitor concentrations. Concentrations higher than 3 μM resulted in increased
cytotoxicity and activation of effector caspases-3/7 as demonstrated by quantification with ApoTox-Glo Triplex Assay. (C) Immunoblot analysis showing that
reactivated cells treated with non-cytotoxic inhibitor concentrations (1 to 2.5 μM) for 24 h revealed a decrease in viral proteins compared with DMSO-treated
samples while cellular proteins remained unaffected. RNAPIIo denotes hypophosphorylated RNAPII. Ser5 and Ser2 RNAPII denote serine 5- and serine 2-
hyperphosphorylated RNAPII forms respectively. (D) Cells were reactivated for 24 h to allow robust viral protein production. Then, DMSO control (0.1%) or
VER-155008 was added in conjunction with cycloheximide (CHX) at 50 μg/ml to block de novo protein synthesis. Protein lysates were collected at several
times post-CHX addition (0, 4, 8, 16 and 24 h) and analysed byWestern blotting. VER-155008 did not alter the half-life of RTA or ORF57 protein, thus these
proteins were not clients of Hsp70 isoforms.
doi:10.1371/journal.ppat.1005274.g003
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Fig 4. VER-155008 abrogated viral protein synthesis pre-translationally in HEK-293T rKSHV.219 cells. (A) Cytotoxicity of VER-155008 was assessed
in unreactivated cells exposed to increasing inhibitor concentrations for 24 h. (i) Cell metabolic activity was reduced in a dose-dependent manner as
quantified using an MTS assay. (ii) Treatment with VER-155008 did not readily cause caspase 3-dependent cleavage of PARP1. Only at 80 μM cleaved (CL)
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The small molecule inhibitor VER-155008 caused a significant reduction
in viral transcripts, viral DNA and progeny at non-cytotoxic
concentrations
As the block in KSHV protein synthesis occurred pre-translationally, viral gene expression was
quantified in the absence or presence of VER-155008. TREx BCBL1-RTA cells were reactivated
for 24 h and two-step quantitative reverse transcription PCR (qRT-PCR) was carried out to
quantify a range of viral transcripts. A significant decrease in early (PAN, ORF57, K12 and
vGPCR), late (gL and gB) viral transcripts and ori-Lyt transcripts was observed in a dose-depen-
dent manner, with all transcripts with the exception of vGPCR being significantly reduced at
an inhibitor concentration of 1 μM (Fig 5A). To determine whether cellular transcription was
negatively affected in the presence of VER-155008, firstly the stability of GAPDH transcript
was determined in mRNA decay assays using the transcriptional inhibitor actinomycin D
(AcD) (2.5 μg/ml) in TREx BCBL1-RTA cells. After 6 h of AcD treatment, the amount of
GAPDHmRNA was reduced by half (Fig 5B), indicating a short stability of GAPDHmRNA in
this cell line. We then plotted the raw cycle threshold (CT) for GAPDH transcript from the
same samples in which viral transcripts had been quantified after 24 h of VER-155008 treat-
ment. As the same amount of total RNA was converted into cDNA for all samples, if cellular
transcription was not compromised a very similar CT is expected for all samples. Indeed,
samples treated with up to 3 μMVER-155008 were all within 0.4 CT from the 12.7 CT of
DMSO-treated samples. Only after concentrations higher than 3 μM GAPDHmRNA levels
were significantly reduced compared to DMSO-treated samples as shown by a significantly
higher CT value (Fig 5C). This is consistent with the cytotoxicity profile of VER-155008 in
TREx BCBL1-RTA cells (Fig 3A and 3B) and the clear decrease in RTA-myc protein (which
expression is not from the KSHV genome) at inhibitor concentrations higher than 3 μM (Fig
3C). Taken together, these results suggest that cellular transcription was compromised at con-
centrations of VER-155008 higher than 3 μMwhile at concentrations lower than 3 μM tran-
scription was occurring normally. Interestingly, transcription of viral genes which also require
host RNAPII for their expression was negatively affected even at VER-155008 concentrations
lower than 3 μM. Next, we assessed whether the inhibitor also caused a reduction in viral DNA
replication. TREx BCBL1-RTA cells were reactivated for 72 h, total DNA was isolated and real-
time qPCR was performed using primers specific for ORF57. While DMSO-treated cells
reached ~ 9-fold increase in viral DNA load, inhibitor concentrations of 2 μM or higher
resulted in a significant reduction (> 30%) in viral DNA (Fig 5D). Moreover, the production
of infectious KSHV virions in TREx BCBL1-RTA cells was evaluated in the presence of VER-
155008 at 2.5 μM or vehicle drug DMSO. For this, cells were reactivated and treated for 72 h,
culture medium was centrifuged and incubated for 24 h with HEK-293T cells. Total RNA was
then isolated and qRT-PCR carried out. A significant reduction (~ 80%) in the release of infec-
tious viral progeny was observed in inhibitor-treated cells (Fig 5E). Viral transcripts were also
quantified at 24 h reactivation in HEK-293T rKSHV.219 cells in the absence or presence of
VER-155008. At non-cytotoxic concentrations of 10 μM there was a drastic decrease for all
PARP1 was observed faintly. (B) Unreactivated cells were exposed for 24 h to increasing inhibitor concentrations. A reduced number of metabolically active
cells accompanied by no increased cytotoxicity was observed in the presence of the inhibitor. There was no activation of effector caspases even in the
presence of 60 μMVER-155008. This phenotype is consistent with cell cycle arrest. Results were quantified with ApoTox-Glo Triplex Assay. (C) Immunoblot
analysis showing that reactivated cells treated with 40 μMVER-155008 for 24 h resulted in abrogation of viral proteins compared with DMSO-treated
samples while cellular proteins remained constant. (D) Cells were reactivated for 24 h to allow robust viral protein expression. Then, DMSO control (0.1%) or
VER-155008 was added in conjunction with cycloheximide (CHX) at 100 μg/ml to block de novo protein synthesis. Protein lysates were collected at several
times post-CHX addition (0, 4, 8, 16 and 24 h) andWestern blotting was performed. As previously seen in TREx BCBL1-RTA cells, VER-155008 did not alter
the half-life of RTA or ORF57 protein.
doi:10.1371/journal.ppat.1005274.g004
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Fig 5. VER-155008 caused a significant reduction in viral transcripts, viral DNA and progeny in TREx BCBL1-RTA cells. (A) Cells were reactivated for
24 h in the presence of control DMSO (0.1%) or a range of increasing inhibitor concentrations, total RNA was isolated and qRT-PCR carried out. Early
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early viral transcripts and ori-Lyt transcripts (Fig 6A). It is intriguing that ORF57mRNA levels
did not show a clear dose-response with the inhibitor as seen for ORF57mRNA in TREx
BCBL1-RTA cells; however the levels were decreased compared with DMSO-control cells. This
is the only transcript of all the viral transcripts tested in both cell lines that did not show a
dose-response. However, Western blotting did reveal a complete reduction of ORF57 protein
in cells treated with> 40 μMVER-155008 (Fig 4C). This suggests that Hsp70 isoforms may
also play a role in the folding of ORF57 protein. In fact, Hsc70 has been previously reported to
associate with at least 15–20% of newly synthesized proteins during their biogenesis [65], thus,
a role for Hsp70 isoforms in folding viral proteins cannot be ruled out. In order to evaluate cel-
lular transcription activity in the presence of VER-155008, we first determined GAPDH tran-
script stability in mRNA decay assays using AcD (10 μg/ml) in HEK-293T rKSHV.219 cells. In
contrast to TREx BCBL1-RTA cells, GAPDH transcripts were very stable, with no significant
reduction in their levels after 10 h of AcD treatment (Fig 6B). The half-lives of two cellular
transcripts, SRAG (a cellular mRNA export adapter) and histone H2A (H2A.1) were also deter-
mined in HEK-293T rKSHV.219 cells. SRAG transcripts were reduced to 50% following 4 h
AcD treatment (Fig 6C), while theH2A.1mRNA was very unstable with nearly 100% reduc-
tion after 2 h AcD treatment (Fig 6D). We then plotted the raw CT values for GAPDH tran-
script from samples in which viral transcripts had been quantified after 24 h of VER-155008
treatment; these did not significantly change in the presence of VER-155008 (Fig 6E). Next,
the unstable SRAG andH2A.1mRNAs were measured in the same samples in which viral tran-
scripts had been quantified after 24 h of VER-155008 treatment. In contrast to viral transcripts,
both cellular transcripts were not significantly reduced, indicating that transcription of cellular
genes was occurring normally even in the presence of high VER-155008 concentrations
(Fig 6F). Taken together, these results demonstrate that inhibition of Hsp70 isoform function
abrogated the expression of viral genes from various temporal classes; however cellular RNA-
PII-mediated transcription was not compromised when using VER-155008 at non-cytotoxic
concentrations.
Hsp70 isoforms are not required for RTA-mediated transactivation of
KSHV promoters
Following quantification of viral transcripts in both cell lines, it appeared that the reduction
seen in viral gene expression, protein production and infectious virion production could be a
consequence of a significant global reduction of viral transcripts in inhibitor-treated cells. This
led to the possibility that Hsp70 isoforms could be implicated in activation of viral promoters
and subsequent transcription or alternatively Hsp70 isoforms were required for KSHV RTC
formation. Because viral RTA and Hsc70 co-localized in TREx BCBL1-RTA cells and RTA is
(orange colour), late (red colour) and ori-Lyt viral transcripts were all significantly reduced at 1 μMVER-155008 compared to the levels found in DMSO-
treated samples. All samples were normalised toGAPDH. Results show the mean of three biological replicates with error bar as standard deviation. (B) The
stability ofGAPDH transcript was assessed in unreactivated TREx BCBL1-RTA cells in the presence of the transcriptional inhibitor actinomycin D (AcD)
(2.5 μg/ml) or control DMSO (0.25%). Cells were collected over the time points indicated and total RNA was extracted followed by qRT-PCR. After 6 h AcD
treatment, the amount ofGAPDH transcripts was reduced by more than half (CT = 18.09) compared with DMSO-treated cells (CT = 16.24). A further reduction
was observed at 8 h treatment (CT = 19.68). The average of two biological replicates with error bar as standard deviation is shown. (C) The amount of
GAPDH transcripts did not significantly decrease when using VER-155008 for 24 h at concentrations lower than 3 μM compared to DMSO-treated samples.
In contrast, concentrations higher than 3 μM significantly showed a CT lower than DMSO samples, indicating compromised cellular transcription at these
inhibitor concentrations. The same samples in which viral transcripts had been quantified were used to plot all CT values. Results show the mean of three
biological replicates with error bar as standard deviation. (D) Cells were reactivated for 72 h, total DNA was isolated and real-time qPCRwas performed. Viral
DNA load was significantly decreased at 2 μMVER-155008. Results show the mean of three biological replicates with error bar as standard deviation. (E)
TREx BCBL1-RTA cells were reactivated for 72 h in the presence of VER-155008 at 2.5 μM or vehicle drug DMSO (0.1%). The culture medium was then
incubated for 24 h with HEK-293T cells followed by total RNA extraction and qRT-PCR. A significant decrease in viral progeny was seen in inhibitor-treated
cells. Results show the mean of three biological replicates with error bar as standard deviation.
doi:10.1371/journal.ppat.1005274.g005
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the master latent-lytic transactivator for multiple KSHV immediate-early, delayed-early and
late promoters [66–70], we further investigated the possibility that Hsc70 was required for
RTA-mediated transactivation. Initially we assessed whether an interaction occurred between
Hsc70 and RTA in the absence of other viral proteins or DNA. For this, HEK-293T cells were
transiently transfected for 24 h with control pEGFP or pRTA-EGFP and immunoprecipitations
were carried out using a GFP-specific antibody. RTA-EGFP precipitated endogenous Hsc70 in
contrast to the control EGFP protein (Fig 7A). In addition, HEK-293T cells were transfected
with control pEGFP or pRTA-EGFP for 24 h and examined by immunofluorescence. In cells
expressing EGFP protein, endogenous Hsc70 remained cytoplasmic (Fig 7Bi), while in
EGFP-RTA-expressing cells Hsc70 strongly co-localised with RTA in the nuclei, suggesting
RTA expression alone is sufficient to redistribute Hsc70 into the nucleus (Fig 7Bii). Similar
nuclear redistribution was also seen for endogenous iHsp70 (S5 Fig). Next, we determined
whether VER-155008 was able to disrupt the interaction between EGFP-RTA and Hsc70 in
HEK-293T cells. HEK-293T cells exhibited a very similar cytotoxicity profile to that seen in
HEK-293T rKSHV.219 cells (S6 Fig). HEK-293T cells were transiently transfected with
pRTA-EGFP or control pEGFP. To allow maximal protein expression and avoid interference
of the inhibitor with the transfection, the inhibitor was added at 24 h post-transfection and
incubated for a further 24 h, prior to immunoprecipitations being performed. Western blot
analysis revealed that the inhibitor did not disrupt the interaction between Hsc70 and RTA
even at high inhibitor concentrations (55 μM) (Fig 7C), suggesting that the ATPase function of
Hsc70 is not required for the interaction with RTA protein.
Therefore, to investigate whether Hsc70 was required for RTA-mediated transactivation of
the RTA-responsive ORF57 promoter, a dual-luciferase reporter assay system was utilised.
HEK-293T cells were co-transfected with pRTA-EGFP along with the Renilla luciferase vector
and either the ORF57 promoter firefly luciferase reporter vector, or the empty reporter vector
(pGL3-BASIC). The same co-transfections were performed using pEGFP, as a negative control.
24 h post-transfection, cells were exposed for 2 h to increasing concentrations of VER-155008
and luciferase activities were measured. Longer exposure times to the inhibitor affected the for-
mation of the control Renilla luciferase protein which has a half-life of 3 h, suggesting that
Hsp70 isoforms may be required for the folding/maturation of this enzyme. In the presence of
EGFP-RTA and the ORF57 promoter reporter construct, the ORF57 promoter activity was
increased ~ 30-fold, while the empty vector had a ~ 4-fold increase. However, ORF57 promoter
activity was not significantly decreased in the presence of VER-155008 (Fig 7D). To confirm
this result, HEK-293T cells were also transiently co-transfected with pPAN-WT, a plasmid
encoding the genomic region of wild type PAN RNA including its promoter region [71], and
either pRTA-EGFP or control pEGFP. 24 h post-transfection either vehicle drug DMSO or
VER-155008 at 45 μMwas added and incubated for a further 24 h followed by qRT-PCR. In
Fig 6. VER-155008 caused a significant reduction in viral transcripts in HEK-293T rKSHV.219 cells. (A) Cells were reactivated for 24 h in the presence
of control DMSO (0.1%) or a range of increasing inhibitor concentrations. Quantification by RT-PCR of immediate-early (blue colour), early (orange colour),
late (red colour) and ori-Lyt viral transcripts showed that all transcripts were significantly decreased at 25 μMVER-155008 compared to the levels found in
DMSO-treated samples. All samples were normalised toGAPDH. Results show the mean of three biological replicates with error bar as standard deviation.
(B-D) The stability of cellularGAPDH, SRAG andH2A.1 transcripts was determined in mRNA decay assays using actinomycin D (AcD) (10 μg/ml) or control
DMSO (1%) in HEK-293T rKSHV.219 cells. Cells were collected over the time points indicated and total RNA was extracted followed by qRT-PCR. The
average of two biological replicates with error bar as standard deviation is shown. (B)GAPDH transcripts were very stable, with no significant reduction in
their levels after 10 h of AcD treatment. (C) At 4 h AcD treatment SRAGmRNA levels were reduced by 50% showing a relatively short stability. (D) H2A.1
mRNA levels were very unstable, with nearly 100% reduction after 2 h AcD treatment. (E)GAPDH transcript levels remained unchanged following 24 h VER-
155008 treatment in reactivated HEK-293T rKSHV.219 cells. The same samples in which viral transcripts had been quantified were used to plot all CT
values. (F) The unstable cellular SRAG andH2A.1mRNAs were not significantly decreased in the presence of VER-155008 treatment compared with DMSO
treatment for 24 h indicating that cellular transcription was not compromised even at high concentrations of VER-155008. The same samples in which viral
transcripts had been quantified were used to quantify SRAG andH2A.1. All samples were normalised toGAPDH.
doi:10.1371/journal.ppat.1005274.g006
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Fig 7. Hsp70 isoformswere not required for RTA-mediated transactivation of KSHV promoters. (A) HEK-293T cells were transiently transfected with
control pEGFP or pRTA-EGFP. 24 h post-transfection immunoprecipitations (IP) were carried out using a GFP-specific antibody. Endogenous Hsc70
interacted with EGFP-RTA but not with the control protein EGFP. (B) HEK-293T cells were transfected with control pEGFP or pRTA-EGFP for 24 h and then
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the presence of EGFP-RTA, but not of control EGFP protein, PAN RNA was synthesised.
However, no significant decrease in the amount of PAN RNA was seen in inhibitor-treated
cells (Fig 7E), indicating that RTA-mediated promoter transactivation and subsequent synthe-
sis of PAN RNA was occurring normally in the presence of VER-155008. These data demon-
strate that Hsp70 isoforms did not directly enhance RTA-mediated transactivation. To assess
the transcription activity of cellular RNAPII in the presence of the inhibitor, the half-life of
PAN RNA was determined in HEK-293T cells co-transfected with pPAN-WT and
pRTA-EGFP. Following 24 h post-transfection, AcD (5 μg/ml) or DMSO control (0.5%) was
added. After 7 h of transcription inhibition, PAN RNA levels were reduced to 25% compared
to DMSO-treated cells (Fig 7F). This quick reduction in the stability of PAN RNA in the
absence of ORF57 protein is in agreement with previous reports [72]. Thus, if VER-155008 was
blocking general RNAPII transcription, a significant reduction in PAN RNA levels should be
observed after 7 h of inhibitor treatment; however, PAN RNA levels were not reduced in cells
treated with VER-155008 for 24 h (Fig 7E).
Inhibition of Hsp70 isoforms abrogated KSHV RTCs formation and
RNAPII re-localization to viral promoters
A dramatic reduction in early, late and ori-Lyt transcripts after 24 h treatment with VER-
155008 was evident during KSHV infection in both cell lines used. However, Hsp70 isoforms
were not required for RTA-mediated transactivation of KSHV promoters in transiently trans-
fected cells. Thus, we next monitored KSHV RTC formation in the absence or presence of the
inhibitor during KSHV lytic infection. TREx BCBL1-RTA cells were reactivated and treated
with either control DMSO or 2 μM inhibitor. At 24 h reactivation cells were fixed and immu-
nofluorescence was performed using RTA- and Hsc70-specific antibodies. DMSO-treated cells
displayed abundant RTCs and numerous nuclear Hsc70 foci that partially co-localised with
RTCs. Hsc70 cytoplasmic depletion was also observed (Fig 8A and 8A’). In contrast, inhibitor-
treated cells showed diffuse nuclear RTA that was not able to assemble into RTCs (Fig 8B and
8B’). In these cells, Hsc70 nuclear foci were still visible, but these were much less numerous
and smaller compared with the foci seen in DMSO-treated cells. Significantly, following
VER-155008 treatment, Hsc70 was observed in the cytoplasm of reactivated cells (Fig 8B and
8B’). Hsc70 subcellular localization was also analysed in DMSO- and inhibitor-treated cells by
confocal profiling. Profiling was performed by drawing a line long enough (~ 20 μm) to cover
the nucleus and cytoplasm at either side of the nucleus. If an Hsc70 pixel intensity data
point was equal or greater than to the data point in the previous and subsequent pixel and
above the background noise, it was considered as an Hsc70 peak, representing an Hsc70 foci.
analysed by immunofluorescence. Endogenous Hsc70 was cytoplasmic in cells expressing EGFP (i). In contrast, Hsc70 strongly co-localised with
EGFP-RTA in the nucleus, but not the nucleoli (ii). (C) HEK-293T cells were transiently transfected with control pEGFP or pRTA-EGFP. 24 h post-
transfection, VER-155008 was added and incubated for a further 24 h. Then, immunoprecipitations were carried out using a GFP-specific antibody. Even in
the presence of 55 μMVER-155008 the interaction between Hsc70 and EGFP-RTA was not disrupted. (D) HEK-293T cells were co-transfected with
pRTA-EGFP along with the Renilla luciferase vector and either theORF57 promoter firefly luciferase reporter vector, or the empty reporter vector
(pGL3-BASIC). The same co-transfections were performed using pEGFP as a negative control protein. 24 h post-transfection, cells were exposed for 2 h to
VER-155008 and luciferase activities were measured. Comparable activation of the RTA-responsiveORF57 promoter to that seen in DMSO-treated cells
occurred in cells treated with 55 μMVER-155008. The results of three independent transfections were averaged with error bars as standard deviation. (E)
HEK-293T cells were transiently co-transfected with pPAN-WT and either pRTA-EGFP or control pEGFP. 24 h post-transfection either vehicle drug DMSO
(0.1%) or 45 μMVER-155008 was added and incubated for a further 24 h. Total RNA was then extracted and qRT-PCR performed. RTA-mediated promoter
transactivation and subsequent synthesis of PANRNA occurred at a similar rate in the presence of VER-155008 or control DMSO. The results of three
independent transfections were averaged with error bars as standard deviation. (F) The stability of PAN RNA was determined in HEK-293T cells that had
been co-transfected with pPAN-WT and pRTA-EGFP. Following 24 h post-transfection, actinomycin D (AcD) (5 μg/ml) or DMSO control (0.5%) was added.
Cells were collected over the time points indicated and total RNA was extracted followed by qRT-PCR. The average of two biological replicates with error bar
as standard deviation is shown.
doi:10.1371/journal.ppat.1005274.g007
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DMSO-treated cells predominantly showed Hsc70 peaks only within the DAPI boundaries,
that is, within the nucleus (Fig 8A”). Inhibitor-treated cells displayed Hsc70 peaks outside the
DAPI boundaries, that is, in the cytoplasm (Fig 8B” asterisk) more often than control cells. A
significant increase in cytoplasmic Hsc70 peaks was seen in inhibitor-treated cells compared
with DMSO control cells (Fig 8C). Fractionation of reactivated TREx BCBL1-RTA cells in the
presence or absence of VER-155008, also pointed to slightly higher levels of Hsc70 in the cyto-
plasm and a decrease in nuclear Hsc70 in inhibitor-treated cells compared with DMSO control
cells (Fig 8D). Cells were also labelled with Click-iT EdU Alexa Fluor 647 and an antibody spe-
cific for Hsc70 (S7 Fig). The percentage of assembled RTCs in DMSO- and inhibitor-treated
cells was also calculated. In DMSO-treated cells ~ 44% of cells presented assembled RTCs while
only 13% of inhibitor-treated cells showed assembled RTCs (Fig 8E). This demonstrates that
chaperone recruitment to the nucleus is essential for the assembly of KSHV RTCs and treat-
ment with VER-155008 was sufficient to impair nuclear chaperone recruitment and KSHV
RTC formation.
The subcellular localisation of RNAPII was also assessed by indirect immunoflourescent
labelling in TREx BCBL1-RTA cells with the monoclonal antibody CTD4H8, which specifically
recognises unphosphorylated and serine-5 phosphorylated RNAPII. In unreactivated cells,
RNAPII exhibited a nuclear localization, excluding the nucleolus (Fig 9Ai arrow) irrespective
of the presence of DMSO (Fig 9Ai) or the inhibitor (Fig 9Aii). However, in reactivated and
DMSO-treated cells, RNAPII was clearly hijacked to RTCs (Fig 9Bi). In contrast, in reactivated
cells treated with the inhibitor, RNAPII was diffuse throughout the nucleus, but excluding the
nucleoli, and formed very small foci (Fig 9Bii arrow) (see higher magnification on S8 Fig).
This suggests that in the presence of Hsp70 isoform inhibition, RNAPII failed to assemble into
developed RTCs and instead aberrantly formed what resembled pre-replicative sites. Cells were
also labelled with Click-iT EdU Alexa Fluor 647 and an antibody specific for RNAPII (S9 Fig).
Similar RNAPII subcellular localisation and cellular DNA replication levels were seen in
DMSO-treated and 2 μM inhibitor-treated unreactivated cells (S9Ai and S9Aii Fig respec-
tively). In DMSO-reactivated cells, cell cycle arrest was evident as shown by fewer Edu-labelled
cells (S9Bi Fig) consistent with previous reports that lytic KSHV in primary effusion lym-
phoma cell lines causes G1 cell cycle arrest [73]. DMSO-treated cells displayed well assembled
RTCs, with few of them showing actively replicating viral DNA (S9Bi Fig). Inhibitor-treated
Fig 8. Inhibition of Hsp70 isoforms prevented Hsc70 chaperone recruitment to KSHV RTCs and RTC formation. (A) TREx BCBL1-RTA cells were
reactivated and treated with control DMSO (0.1%) for 24 h. Multiple KSHV RTCs identified by RTA-labelling were formed in DMSO-treated cells to which
large and numerous Hsc70 foci were recruited. In these cells, Hsc70 was depleted from the cytoplasm. (A’) Confocal images were subjected to profiling
analysis using Zeiss Zen 2011 software. Profiling was conducted for each cell in two representative confocal images taken with a 40-times objective; this
included profiling a total of 49 DMSO-treated cells. A representative line profile (yellow line) and accompanying relative intensities of each channel at every
pixel along the line is shown for a DMSO-treated reactivated cell. The DAPI intensity profile shows values below 25 outside the nucleus boundary. RTA
profile shows a peak with intensity of 160 that lies within the DAPI boundaries corresponding to a KSHV replication compartment. Hsc70 peaks lie within the
DAPI boundaries demonstrating their nuclear location. An Hsc70 intensity peak closely resembles the RTA intensity peak (arrows), indicating co-localization
of Hsc70 with RTA since both peaks occur at the same position along the line. (B) In cells reactivated and treated with 2 μMVER-155008 for 24 h, RTA was
diffuse in the nucleus and not assembled into KSHV RTCs. In addition, Hsc70 nuclear foci were smaller and less abundant than in DMSO-treated cells and
Hsc70 was not depleted from the cytoplasm. (B’). Confocal profiling was performed for each cell in two representative confocal images taken with a 40-times
objective; a total of 68 inhibitor-treated cells were analysed. A representative line profile (yellow line) is shown for an inhibitor-treated cell. An Hsc70 peak is
seen outside the DAPI boundaries corresponding to an Hsc70 cytoplasmic peak (asterisk). (C) Total Hsc70 peaks and total nuclear Hsc70 peaks per cell
were combined for each confocal image and experimental condition. Data was converted to percentage of nuclear and cytoplasmic peaks. From this mean
percentage, standard error of the mean was calculated. (D) Reactivated TREx BCBL1-RTA cells for 24 h in the presence or absence of 2 μMVER-155008
were fractionated into whole cell (WC), cytoplasmic (C) and nuclear (N) fractions. Equal amounts of total protein from each fraction were analysed by
Western blotting. A slight increase in cytoplasmic Hsc70 which correlated with a small decrease in nuclear Hsc70 was detected in inhibitor-treated cells. (E)
The percentage of assembled RTCs in the presence and absence of 2 μMVER-155008 for 24 h was calculated by counting all the cells and corresponding
assembled RTCs present in six representative confocal images taken with a 40-times objective. A total of 227 cells were counted in DMSO-treated cells and
a total of 260 cells in inhibitor-treated cells. DMSO-treated cells had ~ 44% assembled RTCs, in contrast, in the presence of VER-155008, only ~ 13% of the
cells presented well-developed RTCs.
doi:10.1371/journal.ppat.1005274.g008
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cells exhibited very small RNAPII foci and diffuse nuclear Edu labelling (S9Bii Fig). To con-
firm that inhibition of Hsp70 isoform function was able to abolish RNAPII recruitment to viral
genomes, we also utilised chromatin immunoprecipitation (ChIP) assays in TREx BCBL1-RTA
Fig 9. Inhibition of Hsp70 isoforms curtailed RNAPII relocation to KSHV RTCs. (A) TREx BCBL1-RTA cells remained unreactivated and treated with
control DMSO (0.1%) (i) or 2 μMVER-155008 (ii). A polyclonal antibody against RTA and a monoclonal antibody (CTD4H8) against RNAPII were used for
immunoflourescence analysis. RNAPII protein was nuclear excluding the nucleoli (arrows) regardless of inhibitor treatment. (B) TREx BCBL1-RTA cells were
reactivated and treated with either control DMSO (0.1%) or 2 μMVER-155008 for 24 h. In DMSO-treated cells RNAPII and RTA were recruited to viral RTCs
(i arrow) while in inhibitor-treated cells RTA was diffuse in the nucleus and RNAPII formed numerous small foci that excluded the nucleoli and resembled pre-
replicative sites (ii arrow). (C) TREx BCBL1-RTA cells were either reactivated (R) in the presence of DMSO (0.1%) or 2 μMVER-155008 for 24 h.
Unreactivated (U) cells treated with DMSO (0.1%) were used to assess levels of lytic reactivation. ChIP assays were carried out with either monoclonal
CTD4H8 RNAPII antibody or mouse control antibody (IgG). In the presence of VER-155008, significantly reduced amounts of RNAPII bound to viral
promoters were detected. The average of three independent experiments is shown with error bars as standard deviation.
doi:10.1371/journal.ppat.1005274.g009
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cells that were either reactivated for 24 h in the presence of DMSO or 2 μMVER-155008 (Fig
9C). In unreactivated control cells, there was a clear enrichment of RNAPII at the promoter of
GAPDH gene, while RNAPII occupancy at viral promoters was minimal. However, KSHV
reactivation in DMSO-treated cells led to a drastic reduction of RNAPII at the promoter of
GAPDH and a significant increase of RNAPII at the viral promoters in agreement with the
previous immunofluorescence results, showing RNAPII recruitment to RTCs (Fig 9Bi). Con-
versely, upon treatment of theHSP70 inhibitor, the amount of RNAPII bound at the promoters
of ori-Lyt, K12 and ORF59 was decreased by ~ 65%, ~ 70% and ~ 50% respectively compared
with DMSO-treated reactivated cells. Importantly, these results indicate for the first time that
inhibition of Hsp70 isoforms leads to a severe impairment in RNAPII recruitment at multiple
viral promoters including that of ori-Lyt.
Depletion of Hsc70 reduced KSHV lytic transcription
To further confirm the essential role of Hsc70 and iHsp70 in the formation of KSHV RTCs,
specific individual siRNA-mediated depletion of both isoforms was performed in HEK-293T
rKSHV.219 cells. Following four days post-siRNA transfection, cells were reactivated for 24 h
and RNA and protein were extracted from the same sample. Hsc70 depletion was evaluated by
Western blotting and by qRT-PCR, the latter showing ~ 85%Hsc70mRNA knockdown (Fig
10A). In contrast, iHsp70mRNA levels were not affected confirming specificity of the Hsc70
siRNA. Despite a successful knockdown at the mRNA level, significant amounts of Hsc70
protein remained in Hsc70-depleted cells (Fig 10B). However, even with this modest amount
of depletion at the protein level, all viral transcripts (with the exception of PAN) displayed a
significant reduction in Hsc70 siRNA-treated samples compared with the scramble siRNA-
treated cells as demonstrated by qRT-PCR analysis (Fig 10C). ORF57, ORF74 and gLmRNA
levels were decreased by ~ 40% following Hsc70 knockdown. Ori-Lyt and RTA transcripts were
reduced by ~ 30% and gB levels by ~ 20%. This suggests that depletion of Hsc70 impaired the
expression of viral genes from various temporal classes and thus Hsc70 may be necessary for
KSHV RTC formation. Viral DNA replication was also assessed following Hsc70 knockdown.
For this, after four days post-siRNA transfection, cells were reactivated for a further 72 h.
There were no significant differences between scramble and depleted cells (Fig 10D). The pro-
duction of infectious KSHV virions was also evaluated after 72 h reactivation. Again, no signifi-
cant differences were seen between scramble and depleted cells (Fig 10E); however this result
is not surprising due to incomplete Hsc70 depletion even after seven days post-transfection
(Fig 10F). This highlights the remarkable stability of Hsc70 protein in this cell line and it sug-
gests that Hsc70 depletion was enough to cause a reduction in viral transcripts but not enough
to cause a reduction in the amount of viral proteins, thus KSHV lytic replication remained
unaffected. It is also possible that iHsp70 was able to functionally compensate for Hsc70. Next,
specific depletion of iHsp70 was performed in HEK-293T rKSHV.219 cells. iHsp70 depletion
at the mRNA level reached ~ 75% knockdown (Fig 11A) which correlated with efficient deple-
tion at the protein level (Fig 11B). However, in iHsp70-depleted cells, the majority of viral
gene expression was unaffected, apart from gL and PAN transcripts which were decreased by
~ 40% and ~ 20% respectively (Fig 11C). Importantly, taken together these results indicate that
partial depletion of Hsc70 at the protein level is sufficient to cause a reduction in viral tran-
scription, suggesting an essential role of this chaperone in the formation of KSHV RTCs,
whereas iHsp70 may have a more subtle effect on viral gene expression.
To further support the essential role of Hsc70 during KSHV RTC formation, Hsc70 was
specifically silenced in TREx BCBL1-RTA cells. For this, nucleofection was carried out. Trans-
fection efficiency was monitored co-transfecting the Hsc70 siRNA together with pmaxGFP,
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Fig 10. Specific depletion of Hsc70 significantly reduced KSHV lytic transcription in HEK-293T rKSHV.219 cells.Cells were transfected twice with
100 nM Hsc70-specific siRNA or 100 nM scramble siRNA. Following four days post-siRNA transfection, cells were either reactivated for 24 h or remained
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which encodes maxGFP, a green fluorescent protein from the copepod Pontellina p. (Fig 12A).
Note that higher transfection efficiency is expected for the siRNA due to the smaller size of this
compared with the plasmid DNA. After four days post-nucleofection, Hsc70mRNA levels
showed ~ 90% knockdown (Fig 12B) with a minor depletion at the protein level (Fig 12C).
Due to the stability of Hsc70 protein, cells were incubated for six days post-nucleofection fol-
lowed by a further 24 h reactivation and immunofluorescence for Hsc70 and RTA was carried
out. RTC formation dramatically decreased after nucleofection. Similar impairment in KSHV
lytic replication has previously been reported in electroporated TREx BCBL1-RTA cells [74];
nevertheless, in scramble siRNA-treated cells, groups of cells could still be seen displaying
RTCs to which Hsc70 was relocated (Fig 12D). In contrast, in Hsc70 siRNA-treated cells,
fewer RTCs were visible and these exhibited nuclear Hsc70 (Fig 12E yellow arrow) while cells
fully depleted of Hsc70, as identified by lack of Hsc70-labelling, did not form RTCs (Fig 12D
white arrows). This result strongly suggests that Hsc70 is an essential chaperone for the forma-
tion of KSHV RTCs in TREx BCBL1-RTA cells.
Discussion
Current quantitative proteomics approaches have become an invaluable tool for large-scale,
high-throughput identification of proteins in complex biological samples. Moreover, advances
in subcellular fractionation offer a way to further reduce the complexity of the samples to be
analysed by LC-MS/MS, allowing identification of low abundance proteins. In this present
study, we have developed a novel quantitative proteomic approach enhanced by subcellular
fractionation that has enabled us to elucidate the cellular protein composition of KSHV RTCs.
This novel approach led to the identification of several upregulated pathways in reactivated
cells associated with the NE fraction (S2 Table). The first scored pathway was RNA post-tran-
scriptional modification, the second highlighted pathway was protein synthesis with 26 differ-
ent ribosomal proteins identified and the third scored pathway was DNA replication,
recombination and repair. In addition, the isolation of the NE regions from unreactivated and
reactivated cells followed by the uncommon use of urea for protein extraction led to the mass
spectrometric identification of several Hsp70 isoforms and their respective co-chaperones at
significant levels in NE-associated RTCs of reactivated cells. Immunoflourescence analysis con-
firmed that endogenous Hsc70 and iHsp70 were redistributed from the cytoplasm to the
periphery of KSHV RTCs where they formed multiple nuclear foci during early lytic replica-
tion. The formation of RTCs coincided in time with the appearance of nuclear chaperone foci.
Similar virus-induced-chaperone-enriched (VICE) domains that form adjacent to HSV-1
RTCs, have also been observed in HSV-1-infected cells and contain sequestered Hsc70,
iHsp70, Hsp40 and Hsp90 [58, 75, 76]. HSV-1 induced-VICE domains also accumulate
ubiquitinated proteins and components of the proteasome and function to sequester misfolded
proteins away from RTCs and serve as protein quality control centers [75, 77]. iHsp70 redistri-
bution very similar to that seen in HSV-1 induced-VICE domains was observed in multiple
unreactivated and total RNA and protein were extracted from the same sample. Despite achieving ~ 85% Hsc70 knockdown at the mRNA level (A),
significant amounts of Hsc70 protein remained in Hsc70 siRNA-treated samples (B). Despite this small knockdown at the protein level, in Hsc70-depleted
cells there was a significant decrease in the amount of multiple viral transcripts from various temporal classes as quantified by RT-PCR analysis (C). Viral
DNA replication was assessed by qPCR following Hsc70-knockdown. Cells were reactivated for 72 h after four days post-siRNA transfection. No significant
differences were observed between scramble and Hsc70-treated cells (D). Similar virion production was detected in scramble and Hsc70-treated cells. Cells
were reactivated for 72 h after four days post-siRNA transfection, culture medium was centrifuged and immediately incubated with HEK-293T cells for 24 h.
Total RNA was then isolated and qRT-PCR carried out (E). Incomplete Hsc70-knockdown at the protein level was observed byWestern blotting even after
seven days post-siRNA transfection in HEK-293T rKSHV.219 cells. This demonstrates the remarkable stability of Hsc70 in this cell line (F). The average of
three independent transfections is shown with error bars as standard deviation (A, C-E).
doi:10.1371/journal.ppat.1005274.g010
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Fig 11. The majority of KSHV lytic gene expression was unaffected following specific depletion of iHsp70 in HEK-293T rKSHV.219 cells. Cells were
transfected twice with 100 nM iHsp70-specific siRNA or 100 nM scramble siRNA. Following four days post-siRNA transfection, cells were either reactivated
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cells undergoing KSHV lytic replication, moreover this labelling was also observed for Hsc70
in some cells. Hsc70 and iHsp70 remain positioned exclusively adjacent to HSV-1 RTCs. How-
ever, in contrast; these chaperones were very dynamic during KSHV lytic replication and sur-
prisingly very large chaperone foci were recruited within KSHV RTCs when viral DNA was
actively synthesised (Fig 2C and S1B Fig). Therefore, our results strongly suggest that these
chaperones may also aid replication of KSHV genomes during lytic replication. We therefore
further suggest that Hsp70 isoforms may have an important role in the assembly and activation
of pre-initiation complexes on the origin of DNA replication. This is supported by observations
in prokaryotes, such as in plasmid P1 [78, 79], and eukaryotes, such as Saccharomyces cerevi-
siae [80], human papillomavirus-11 [81, 82], HSV-1 [83] and bacteriophage λ [84, 85]. Inter-
estingly, Hsp70 isoforms have also been identified in the KSHV virion [86, 87] and therefore
an additional role of these chaperones in KSHV capsid assembly may also be possible.
Cancer cells greatly rely on members of the HSP70 and HSP90 chaperone families for their
growth and survival [5, 88], consequently, significant efforts have been invested to design small
molecule inhibitors specific for these ATPases as novel anticancer therapeutics. This has been
successfully achieved for the HSP90 family with several inhibitors undergoing phase III clinical
trials [14], although the clinical efficacy of these inhibitors has been somewhat limited because
of the inevitably upregulation of iHsp70, when inhibiting Hsp90 [56, 57]. The development of
HSP70 inhibitors has substantially lagged behind that of HSP90 inhibitors due to lack of natu-
ral product inhibitors specific for Hsp70 isoforms, due to the highly polar nature of the Hsp70/
Hsc70 ATP binding site and the high affinity for ATP displayed by these ATPases [12]. Never-
theless, in recent years several HSP70 inhibitors have been designed and tested in pre-clinical
or clinical trials [88]. However, a major challenge remains in finding inhibitors which can spe-
cifically discriminate between iHsp70 and Hsc70. To date, only peptide aptamers targeting
iHsp70 are selective for a specific Hsp70 isoform [89] and also recently, methyl blue was
reported to specifically inhibit iHsp70 by oxidizing a cysteine in its ATPase domain, the same
residue is absent in Hsc70 allowing differential targeting of the isoforms [90]. Because both
Hsc70 and iHsp70 were specifically redistributed to KSHV RTCs during lytic replication, we
made use of a recently developed small molecule inhibitor, VER-155008, which targets the
ATPase pocket of the main three human Hsp70 isoforms. This inhibitor used at non-cytotoxic
concentrations was able to effectively abrogate early and late KSHV transcription together with
viral protein production, viral DNA replication and viral progeny.
Therefore, our study highlights the potential of VER-155008 or other novelHSP70 inhibi-
tors to prevent KSHV lytic replication in KSHV-associated tumours. One could expect that
HSP70 inhibition would be directly detrimental not only to cancer cell survival but also the
virus-specific functions that are dependent on Hsp70 isoforms. These results may have exciting
implications in combination with the recently demonstrated efficacy of ATP-competitive
HSP90 inhibitors in blocking KSHV latent cycle in vitro and in a xenograft KSHV tumour
model [41]. It may be the case that combining HSP70 inhibitors with HSP90 inhibitors may
lead to enhanced efficacy in eradicating latent KSHV reservoirs. Excitingly, in our cell culture
models VER-155008 abrogated lytic replication without severely affecting cell viability or trig-
gering apoptosis. It is intriguing that inhibition of constitutively expressed Hsc70 chaperone
did not result in cell death. However, it is important to highlight previous studies carried out
on the susceptibility of tumour cells versus normal cells toHSP90 inhibitors. In tumour cells,
for 24 h or remained unreactivated and total RNA and protein were extracted from the same sample. Efficient iHsp70 knockdown was achieved both at the
mRNA level (~ 75%) (A) and the protein level (B). A small decrease in the amount of gL and PAN transcripts was observed in iHsp70-depleted cells (C). The
average of three independent transfections is shown with error bars as standard deviation.
doi:10.1371/journal.ppat.1005274.g011
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Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity; in contrast,
in normal cells Hsp90 is in an uncomplexed conformation. These two distinct Hsp90 presenta-
tions result in tumour Hsp90 exhibiting a 100-fold higher binding affinity to anHSP90 inhibi-
tor than normal Hsp90 [91]. Thus, it is tempting to speculate that the multi-chaperone HSP70
foci that are recruited to KSHV RTCs during lytic replication (Fig 2 and S1 Fig) are more sen-
sitive to VER-155008 than the chaperones not assembled in VICE domains which carry out
the housekeeping functions for cell survival. This would explain whyHSP70 inhibition had a
profound effect on KSHV lytic replication without affecting cell viability and support the idea
that isoform specificity may not be a requirement for treatment of KSHV-associated tumours.
To establish the essential role of Hsp70 isoforms during KSHV lytic replication, we exam-
ined several possible functions. It could be hypothesised that Hsp70 isoforms could be impli-
cated in 1) stabilization of essential viral proteins, 2) clearing stalled RNAPII during times of
robust viral transcription, 3) activation of viral promoters, 4) formation of KSHV RTCs. Ini-
tially we hypothesised that Hsp70 isoforms may be necessary for maintaining the stability of
the key KSHV viral proteins RTA and/or ORF57. This was deemed a possibility as during
KSHV latency, the essential viral latency associated nuclear antigen (LANA) protein has been
recently shown to be a client protein of the Hsp90 chaperone and several HSP90 inhibitors
reduced the expression of LANA [41]. In addition, the lytic KSHV K1 glycoprotein has also
been reported to be a client protein of Hsp90 [92]. However, inhibition of Hsp70 isoforms did
not alter the half-life of RTA or ORF57 (Figs 3D and 4D). Alternatively, Hsc70 has been
observed at the periphery of HSV-1 RTCs where it is also believed to aid in clearing stalled
RNAPII from viral genomes during times of active transcription [76]. Indeed, the serine-2
phosphorylated form of RNAPII undergoes ubiquitination and robust proteasomal degrada-
tion during HSV-1 infection [93]. In contrast, in KSHV-reactivated cells, there was only a slight
reduction of serine-2 phosphorylated RNAPII in comparison with unreactivated cells even at
late times (24 h) post-reactivation (Fig 3C) and a significant decrease in the other RNAPII
forms was not evident (Fig 3C). This suggests that although robust RNAPII degradation is a
feature observed in virus infection, such as HSV-1 and influenza virus [55, 93], it may not be
universally conserved. It is interesting to note that expression of a dominant-negative Hsc70
(K71M) that cannot hydrolyze ATP during HSV-1 infection resulted in prevention of serine-2
RNAPII degradation and RTCs formation [76]. However, inhibition of Hsp70 isoforms by
VER-155008 did not prevent the slight degradation of phospho-serine-2 RNAPII protein (Fig
3C). Using transient transfections, we also demonstrated that Hsp70 isoforms were not directly
involved in the activation of viral promoters (Fig 7D and 7E). Strikingly however, inhibition of
Hsp70 isoforms precluded KSHV RTCs formation (Fig 8) and RNAPII re-localization to viral
promoters (Fig 9), thus, blocking KSHV RTCs formation led to abolishment of global viral
transcription and subsequent protein synthesis and viral DNA replication. These results, taken
together with the differential Hsc70 and iHsp70 labelling seen in HSV-1 and KSHV-infected
cells, suggest that these chaperones may be playing additional roles, such as participating in
viral DNA replication and/or capsid assembly, in KSHV lytic infection compared with HSV-1
infection. Importantly, in both viruses, HSV-1 and KSHV, inhibition of Hsc70 ATPase
Fig 12. Depletion of Hsc70 abrogated KSHV RTC formation in TREx BCBL1-RTA cells. (A) Cells were nucleofected with either scramble or
Hsc70-specific siRNA together with pmaxGFP to monitor transfection efficiency. 48 h post-nucleofection cells were imaged by fluorescent and light
microscopy with a 40-times objective. Merge images are shown. (B) After four days post-nucleofection, total RNA was isolated and qRT-PCR carried out.
Hsc70mRNA levels showed ~ 90% knockdown, in contrast iHsp70mRNAwas significantly increased. (C) A minor Hsc70 depletion at the protein level was
observed at four days post-nucleofection while iHsp70 was clearly upregulated in Hsc70 siRNA-treated cells as shown byWestern blotting. (D and E) Six
days post-nucleofection cells were reactivated for 24 h and immunofluorescence was performed with RTA and Hsc70 specific antibodies. (D) In scramble
siRNA-treated cells RTCs to which Hsc70 was recruited were observed. (E) In Hsc70 siRNA-treated cells, cells nearly or completely depleted of Hsc70
protein did not form RTCs (white arrows), while cells presenting assembled RTCs still displayed Hsc70 nuclear foci (yellow arrows).
doi:10.1371/journal.ppat.1005274.g012
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function leads to a clear impediment in RTCs formation and presents a novel antiviral target
for multiple herpesviruses. Moreover, as HSV-1 and KSHV belong to different subfamilies of
theHerpesviridae family (α and γ subfamily respectively), the key role of Hsp70 isoforms in
RTC formation may be conserved across all subfamilies. In support of this notion is the fact
that Hsc70 and iHsp70 have also been reported to be incorporated in the virion of the β-her-
pesvirus HCMV [94] and the γ-herpesvirus EBV [95]. Our results also support that the finding
of Hsc70 and iHsp70 chaperones in the KSHV virion [86, 87] a decade ago was not casual, and
that these chaperones are essential for KSHV RTCs formation during lytic replication. iHsp70
has also been detected in the HSV-1 virion [96]. To support the conserved role of Hsp70 iso-
forms in herpesvirus infection, a recent study showed that cellular depletion of Hsc70 protein
significantly reduced HSV-1 viral output in cell culture without adversely affecting cell viabil-
ity. Depleting Hsc70 from the HSV-1 virion also significantly reduced viral production by
more than 50% [97].
Hsp70 isoforms may be recruited to RTCs for several reasons. Firstly, the chaperone may
sequester misfolded, modified or unwanted proteins away from RTCs. Alternatively, Hsp70
could produce a site for protein remodelling and/or degradation which may regulate or delay
cellular pathways, such as the apoptosis cascade. Finally, it may aid subtlety to clear stalled
RNAPII complexes during robust viral transcription and replication. An additional question
which is yet to be addressed is the mechanism by which Hsp70 isoforms are recruited to RTCs.
One intriguing possibility is observations made during HSV-1 infection. Here, HSV-1 ICP27
has been shown to interact with Hsc70 and is required for Hsc70 nuclear foci formation [76]. It
will now be interesting to determine if the functional KSHV homologue ORF57, also interacts
with Hsc70 and whether its nucleocytoplasmic shuttling ability is essential for Hsc70 nuclear
import.
In summary, we have identified a new essential role for Hsp70 isoforms during the forma-
tion of RTCs in KSHV lytic replication. Importantly, our results suggest that HSP70 inhibitors
have the potential as novel KSHV antiviral agents and it would now be interesting to test these
in conjunction with other molecular chaperone inhibitors, specificallyHSP90 inhibitors [41],
which have the potential to eradicate latent KSHV reservoirs in both in vitro and in vivo
tumour models.
Materials and Methods
Cell culture, antibodies and reagents
TREx-BCBL-1-RTA cells (kindly provided by Dr. Jae Jung, University of Southern California)
are a BCBL-1-based, primary effusion lymphoma (PEL) B cell line that has been engineered to
inducibly express exogenous Myc-tagged RTA by the addition of doxycycline, leading to a
robust reactivation of the full KSHV lytic cycle [48]. The rKSHV.219 cell line (kindly provided
by Dr. Jeffery Vieira, University of Washington, Seattle, USA) maintains KSHV as a latent
infection and was generated by infecting HEK-293T cells (ATCC) with a recombinant KSHV
that contains a constitutively active puromycin resistance and GFP gene, and an RFP gene that
is fused to an RTA-responsive lytic cycle (PAN) promoter; hence, expression of RFP can be
used as a reporter of RTA activity [42]. HEK-293T rKSHV.219 cells were grown in DMEM
(Life Technologies) supplemented with 10% foetal calf serum (FCS) (Life Technologies) and
1% penicillin/streptomycin (P/S). This cell line was kept under puromycin (Sigma) selection
(0.2 μg/ml). Reactivation into the lytic cycle was achieved by addition of 12-O-tetradecanoyl-
phorbol 13-acetate (TPA) (20 ng/ml) and sodium n-butyrate (NaB) (Sigma) (4 mM). The
TREx BCBL1-RTA cell line was grown in RPMI 1640 medium (Life Technologies) supple-
mented with 10% FCS and 1% P/S. This cell line was kept under hygromycin B (Life
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Technologies) selection (100 μg/ml) and inductions were performed using 2 μg/ml doxycycline
hyclate (Sigma) as previously described [98]. All cells were maintained at 37°C in a humidified
incubator with 5% CO2. Plasmid transfections were carried out using Lipofectamine 2000 (Life
Technologies), as previously described [99]. Luciferase assay plasmids Renilla luciferase vector
pRL-TK and firefly luciferase vector pGL3-BASIC were purchased from Promega, pEGFP-N1
was obtained from Clontech, pRTA-EGFP and pPAN-WT have been previously described [71,
100].
The monoclonal mouse antibodies to anti-nuclear pore complex proteins (mAb414)
(ab24609), GAPDH (6C5), rabbit polyclonal anti-lamin B1 and anti-Ser2 RNAPII were pur-
chased from Abcam. The rabbit polyclonal anti-histone H3 C-terminus (39164) was purchased
from Active Motif. The rabbit polyclonal anti-Nup160 was obtained from Bethyl Laboratories.
Monoclonal antibodies to KSHV ORF57 (207.6), to Hsc70 (B-6), to Grp78 (A-10), to Hsp90
(4F10), to B-23 (0412) and to C-23 (H6) were obtained from Santa Cruz. The mouse monoclo-
nal (C92F3A-5) anti-iHsp70 was from Enzo Life Sciences. The rabbit polyclonal anti-PARP1
was purchased from Cell Signalling. The mouse monoclonal (CTD4H8) anti-RNAPII was pur-
chased fromMillipore. The mouse monoclonal (9E10) anti-c-Myc was from Sigma. Sheep
anti-KSHV minor capsid protein was purchased from Exalpha Biologicals, Inc. The rabbit
polyclonal anti-RTA was a gift from Professor David Blackbourn (University of Surrey, UK).
The mouse monoclonal (JL-8) anti-GFP was supplied by Clontech. The inhibitor for Hsp70
isoforms (VER-155008) was obtained from Tocris Bioscience.
SILAC and nuclear envelope isolation
For SILAC, HEK-293T cells rKSHV.219 were fed with either medium (R6K4) or light (R0K0)
labelled medium (Dundee Cell Products) containing 10% dialysed FCS (Dundee Cell Products)
for six passages to allow incorporation of the isotopes, as previously described [101]. Subse-
quently, to induce lytic replication three T175 flasks were reactivated with TPA (20 ng/ml) and
NaB (4mM) for 48 h, while another three T175 flasks remained unreactivated as control. To
isolate NEs a protocol published by Korfali et al., [35] was used with minor modifications. 75
million cells were used per experimental condition. Cells were washed with PBS and incubated
in hypotonic lysis buffer (10 mMHEPES pH 7.4, 1.5 mMMgCl2, and 10 mM KCl) for 30 min
followed by homogenization with a tight Dounce homogenizer. To stabilise and avoid lysing
the nuclei after the hypotonic swelling step, cells were resuspended in 2.2M SHKM (2.2 M
sucrose, 50 mMHEPES pH 7.4, 25 mM KCl, and 5 mMMgCl2) and 1M KCl. The resuspended
cells were then underlayed with 30% SHKM (0.9 M sucrose, 50 mMHEPES pH 7.4, 25 mM
KCl, and 5 mMMgCl2) and nuclei were pelleted at 2,000xg for 20 min at 4°C in a Eppendorf
centrifuge 5804 R. Nuclei were resuspended in 1.9 M SHKM, underlayed with 2.2 M SHKM
and transferred to 38.5-ml ultracentrifuge tubes (Beckman Coulter). Nuclei were then centri-
fuged at 82,000xg for 2h at 4°C in a Sorvall Discovery 90SE ultracentrifuge. Pellets were resus-
pended in 0.25 M SHKM (50 mMHEPES pH 7.4, 25 mM KCl, and 5 mMMgCl2), treated with
1% Triton-X in 10% SHM (0.3 M sucrose, 10 mMHEPES, pH 7.4, 2 mMMgCl2 and 0.5 mM
Ca Cl2) for 10 min and centrifuged at 2,000xg for 10 min. Nuclei were then treated with RNase
A (Thermo Scientific) and DNase I (Life Technologies) for 15 min, pelleted at 6,000xg for 10
min, resuspended in 10% SHM and treated again with RNase A and DNase I for 15 min. Nuclei
were centrifuged at 2,000xg for 10 min, resuspended and incubated for 15 min in 10% SHM
containing 0.3 M NaCl to remove nucleoplasmic contents. Nuclear envelopes were then pel-
leted at 1,500xg for 15 min. Insoluble nuclear envelope proteins were solubilised for 10 min in
PBS supplemented with 0.1% Triton-X100 and 6 M urea. Samples were centrifuged at 6,000 g
for 2 min to remove insoluble material and the supernatant containing nuclear envelope
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proteins was stored at -80°C for further Western blotting and mass spectrometry analysis. All
solutions had freshly added 1x Complete, EDTA-free protease inhibitors (Roche). DTT (2
mM) was also freshly added to the solutions specified on Korfali’s protocol. LC-MS/MS was
performed as previously described [22]. Bioinformatical analysis was performed with the Inge-
nuity Systems software packet, IPA 9.0 (Ingenuity Systems, Inc).
Immunoprecipitation andWestern blotting
Protein samples were extracted using lysis buffer containing 50 mM Tris (pH 7.4), 150 mM
NaCl, 1% NP-40 and 1x Complete, EDTA-free protease inhibitors (Roche) for 30 min on ice,
as previously described [102]. Protein samples were run on SDS-PAGE gels and transferred
to nitrocellulose membranes (Amersham) via wet transfer. Membranes were blocked with
TBS + 0.1% Tween 20 and 5% dried skimmed milk powder. Membranes were probed with rele-
vant primary and secondary antibodies, treated with EZ-ECL (Geneflow) and exposed to
Amersham hyperfilm ECL (GE Healthcare). Secondary antibodies were horseradish peroxidase
(HRP)-conjugated polyclonal goat anti-mouse and polyclonal goat anti-rabbit (Dako). HRP-
conjugated polyclonal rabbit anti-sheep was from Santa Cruz. GFP-Trap (Chromotek) experi-
ments were performed as previously described [103]. Nuclear/cytoplasmic fractionations were
performed as previously described [44], with the exception that nuclear pellets were solubilised
for 20 min in PBS supplemented with 0.1% Triton-X100 and 6 M urea. Vigorous pipetting and
vortexing was applied to the nuclear pellet. After urea treatment, insoluble material was
removed by centrifugation at 6,000 g for 2 min and the supernatant kept for further analysis.
Immunoflourescence
Cells were cultured overnight on poly-L-lysine (Life Technologies) coated glass coverslips in
24-well plates. Cells were fixed with 4% formaldehyde (Calbiochem) for 10 min and permeabi-
lised with 0.1% Triton X-100 for 20 min as previously described [104]. For labelling with
Grp78 antibody cells were fixed with ice-cold 100% methanol for five min. After permeabiliza-
tion, cells were then incubated in blocking solution (PBS with 1% BSA) for 1 h at 37°C. Primary
antibodies anti-Hsc70 (diluted 1:200), anti-iHsp70 (1:50), anti-Grp78 (1:50), anti-RNAPII
(CTD4H8) (1:500) or rabbit RTA (1:1,000) were incubated for 1 h at 37°C. Coverslips were
washed five times with PBS, incubated with appropriate secondary antibody for 1 h at 37°C,
washed five times with PBS again and mounted in VECTASHIELD with DAPI (Vector Labs).
Images were obtained using a LSM 510 META confocal microscope (Carl Zeiss) and processed
using ZEN 2009 imaging software (Carl Zeiss) as previously described [105]. Fluorescently-
conjugated secondary antibodies were all obtained from Life Technologies: Alexa Flour 633
goat anti-mouse IgG, Alexa Flour 488 goat anti-mouse IgG, Alexa Flour 488 goat anti-rabbit
IgG, Alexa Flour 546 donkey anti-mouse IgG and Alexa Flour 546 goat anti-rabbit IgG.
Edu assay
TREx BCBL1-RTA cells were labelled using the Click-iT EdU Alexa Fluor 647 Imaging Kit
(Life Technologies) according to the manufacturer’s instructions with minor modifications as
follows. Cells were seeded onto poly-L-lysine treated coverslips in 24-well plates followed by
induction and incubation at 37°C for 24 hours. Prior to cell fixation, 10 μM EdU (5-ethynyl-2’-
deoxyuridine) was added to each well for 45 min. Cells were then fixed for 10 min in 4% form-
aldehyde and permeabilised in 1% Triton X-100 for 20 min. Edu detection was carried out add-
ing the Click-iT reaction cocktail for 30 min and immunofluorescent labelling for RTA and
Hsc70 was performed as above. Cells were mounted in VECTASHIELD with DAPI (Vector
Labs).
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Two-step quantitative reverse transcription PCR (qRT-PCR)
Total RNA from cells was extracted using TRIzol (Life Technologies) according to the suppli-
er’s protocol. DNA-free DNA Removal Kit (Ambion) was used to remove any contaminating
DNA from RNA samples. Reverse transcription was performed with ProtoScript II (NEB) and
oligo(dT) primers and 1.5 μg of total RNA. Negative control reactions were performed in the
same manner but without reverse transcriptase. Quantitative PCR (qPCR) reactions (20 μl)
included 1X SensiMix SYBR green master mix (Bioline), 0.5 μM of each primer and 5 μl tem-
plate cDNA (used at 1:200 dilution in RNase-free water). Cycling was performed in a Rotor-
Gene Q machine (Eppendorf). The cycling programme was a 10 min initial preincubation at
95°C, followed by 40 cycles of 95°C for 15 sec, 60°C for 30 sec and 72°C for 20 sec. After qPCR,
a melting curve analysis was performed between 65 and 95°C (with 0.2°C increments) to con-
firm amplification of a single product. Relative expression compared to control cells was calcu-
lated using the ΔΔCTmethod as previously described [106]. For each gene of interest and
housekeeping gene (GAPDH) a standard curve was constructed using a pool of cDNA derived
from unreactivated and reactivated cells. Six different dilutions of the standards were quanti-
fied, these included 1:100, 1:200, 1:400, 1:800, 1:1,600 and 1:3,200 dilution. The slope of the
standard curve was used to calculate the amplification efficiency (AE) of the primers using the
formula: AE = (10−1/slope). The mean cycle threshold (CT) was determined from three indepen-
dent biological replicates. All genes of interest were normalised against the housekeeping gene
GAPDH (ΔCT). ΔΔCT was calculated subtracting ΔCT of unreactivated cells from ΔCT of reacti-
vated cells and the fold change was then determined using AE (-ΔΔCT
). Statistical significance
was validated by Student’s t-test.
Viral DNA replication assays
Unreactivated TREx BCBL1-RTA cells treated with DMSO (0.1%) were used as control to
assess viral reactivation. Reactivated cells were exposed to doxycycline for 72 h. Total DNA was
then isolated with the use of a QIAamp DNA mini kit (Qiagen) as per the manufacturer’s
instructions. qPCR was carried out as described above. 10 ng of template DNA and primers
specific for the ORF57 gene were used. Quantification of GAPDH gene was used to normalize
between samples and the mean cycle threshold (CT) was determined from three independent
biological replicates. Relative levels of viral DNA compared with unreactivated cells were calcu-
lated using the ΔΔCTmethod as previously described [106].
Viral re-infection assays
TREx BCBL1-RTA cells that had been seeded on 12-well plates were reactivated and treated
with control DMSO (0.1%) or VER-155008. Unreactivated cells treated with DMSO (0.1%)
were used as control to evaluate viral reactivation. After 72 h reactivation, 700 μl of the RPMI
1640 culture medium was centrifuged at 800 g for five min, immediately mixed with 300 μl of
DMEM supplemented with 10% FCS and 1% P/S and incubated for a further 24 h with HEK-
293T cells that had been seeded in 12-well plates the previous day. Total RNA was then
extracted with TRIzol (Life Technologies) and qRT-PCR carried out as described above. Rela-
tive expression compared to control cells was calculated using the ΔΔCTmethod as previously
described [106].
Proliferation (MTS) assay
Determination of the cellular metabolic activity was performed using a non-radioactive CellTi-
ter 96 AQueous One Solution Cell Proliferation Assay (MTS) (Promega), according to the
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manufacturer's manual. 20,000 cells TREx BCBL1-RTA or 10,000 HEK-293T rKSHV.219 cells
were seeded in triplicate in a flat 96-well culture plate (Corning). After 24 h inhibitor exposure,
CellTiter 96 AQueous One Solution Reagent was added and cells were incubated for 1 h in a
humidified incubator in 5% CO2 at 37 °C. Absorbance was measured at 490 nm using an Infi-
nite F50 (Tecan) plate reader. Background control had culture medium without cells and the
signal from this was subtracted to all other absorbance values.
ApoTox-Glo Triplex Assay
This assay allows evaluation of viability, cytotoxicity and effector caspases activation within a
single assay well. The assay was carried out as specified on the supplier’s manual. 20,000 TREx
BCBL1-RTA cells or 10,000 HEK-293T rKSHV.219 cells were seeded in triplicate in tissue cul-
ture treated black microplates (Greiner Bio-One). No-cell control (background) contained
only culture medium and the signal from this was subtracted to all other absorbance and lumi-
nescence values. Fluorescence and luminescence readings were collected using a GloMax Sys-
tem (Promega) (kindly provided by Dr. John Boyle, University of Leeds, UK).
Dual-Luciferase assay
Luciferase activity was detected using the Dual-Luciferase Reporter Assay System (Promega) as
previously described [107]. HEK-293T cells were seeded in triplicate in flat 96-well culture
plate (Corning) at a density of 10,000 cells per well. Following the respective plasmid transfec-
tions and inhibitor exposure, media was removed from the culture wells and cells washed
gently with 100 μl PBS. 30 μl 1x passive lysis buffer was added to the cell monolayer which was
rocked for 15 min and then 20 μl of each lysate was transferred to tissue culture treated white
microplates (Greiner Bio-One). Luciferase measurements were carried out in a FLUOstar
Optima microplate reader (BMG Labtech Ltd), with injectors 1 and 2 being used to dispense
50 μl of Luciferase Assay Reagent II and Stop & Glo Reagent respectively. Firefly luciferase
activity was normalized to Renilla luciferase activity.
Chromatin immunoprecipitation (ChIP)
Formaldehyde-crosslinked chromatin was prepared using the Pierce Chromatin Prep Module
(Thermo Scientific) following the manufacturer’s protocol. 2 x 106 cells were used per experi-
mental sample and digested with six units of micrococcal nuclease (MNase) per 100 μl of
MNase Digestion buffer in a 37°C water bath for 15 min. These conditions resulted in optimal
sheared chromatin with most chromatin fragments ranging from 150–300 base pairs. Immu-
noprecipitations were carried out using EZ-ChIP kit (Millipore) according to the supplier’s
instructions and as previously described [44]. Immunoprecipitations were done overnight at
4°C and contained 50 μl of digested chromatin (2 x 106 cells), 450 μl of ChIP dilution buffer
and 1.5 μg of RNAPII antibody (clone CTD4H8) (Millipore) or isotype antibody, normal
mouse IgG (Millipore). Both antibodies were provided with the EZ-ChIP kit. Prior to qPCR
analysis, eluted DNA was subjected to a DNA clean up step using UltraClean PCR Clean-Up
Kit (Mo Bio Laboratories) according to the supplied protocol with the exception of using
500 μl of SpinClean buffer instead of 300 μl. qPCR reactions were performed as described
above and using either 2 μl of ChIP’ed DNA or 2 μl of input DNA as template.
siRNA Knockdown
HEK-293T rKSHV.219 cells seeded on 12-well plates were reverse transfected with either
100 nM of the specific Silencer Select siRNA (Life Technologies) or 100 nM AllStars negative
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control siRNA (Qiagen) using 7 μl of siPORT NeoFX transfection agent (Life Technologies)
per transfection. The siRNA ID for Hsc70 and iHsp70 were s6985 and s6968 respectively. s6968
siRNA targets the two major iHsp70 proteins (HSP70-1 and HSP70-2). Two days post-trans-
fection, cells were transfected again in the same manner. Four days after the first transfection,
cells were reactivated and incubated for the desired time. Proteins and total RNA were isolated
with TRIzol (Life Technologies) and subsequent Western blot and qRT-PCR were performed.
8 × 106 TREx BCBL1-RTA cells were transfected once with 100 μl of Nucleofector solution
V (Lonza) to which 2 μM siRNA (scramble or Hsc70) was added. In addition, to monitor trans-
fection efficiency, 1 μg of the control plasmid pmaxGFP was also co-transfected. Cells were
transfected using program T-01 of an Amaxa nucleofector I (Lonza). After nucleofection cells
were maintained in six-well plates. Medium was freshly replaced every day.
Confocal profiling analysis
Confocal images were subjected to profiling analysis using Zeiss Zen 2011 software. This
involved drawing a line in a confocal image to measure the relative intensity of each channel at
every pixel along the line. Profiling was conducted for each cell in two representative confocal
images taken with a 40-times objective. These data were then analysed using Microsoft Excel
2010. Firstly, a function was used to define whether the relative intensity of a pixel could be
defined as a “peak” and thus an Hsc70 foci. This function asked whether the data point for one
specific pixel of the rhodamine channel was 20, this was set as the arbitrary threshold to
eliminate background noise. If this condition was met, the function then asked whether the
data point was greater than or equal to the data point in the previous and subsequent pixel. If
these conditions were true, then this data point was counted as a peak. This was performed for
every data point measured in the line profile providing the total number of Hsc70 peaks in the
profile of one cell. Next, another function was used to determine whether the relative intensity
in the DAPI channel was 25, a threshold determined from visualising the line profiling data
as a graph. If a pixel was shown to exceed the threshold in the DAPI channel and also in the
rhodamine channel, then it was counted as a nuclear Hsc70 peak. These measurements were
conducted for each pixel in each profile allowing counting Hsc70 nuclear peaks in each profile.
Hsc70 peaks outside the nucleus corresponded to cytoplasmic Hsc70 peaks.
Oligonucleotides
Oligonucleotide primer sequences are available upon request. All primers were purchased
from Sigma (UK).
Supporting Information
S1 Table. Cellular proteins previously reported to localise to herpesvirus RTCs and found
significantly increased in the NE of reactivated cells.
(PDF)
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pathways upregulated in nuclear envelopes during KSHV infection.
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S1 Dataset. List of all proteins identified by LC-MS/MS in the NE-fractions of unreacti-
vated and reactivated HEK-293T rKSHV.219 cells.
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S1 Fig. iHsp70 was redistributed from the cytoplasm to both the periphery and within
KSHV-induced RTCs. (A) TREx BCBL1-RTA cells remained unreactivated or reactivated for
either 20 h or 24 h. In unreactivated cells iHsp70 was cytoplasmic (i). In contrast, at 20 h reacti-
vation an increase in nuclear iHsp70 labelling was seen with numerous small iHsp70 foci
found mainly adjacent to viral RTCs (ii). Some cells displayed iHsp70 completely recruited
within RTCs (iii and iv asterisks), while other cells accumulated large iHsp70 adjacent to RTCs
(iv arrows). (B) TREx BCBL1-RTA cells remained unreactivated (i) or reactivated for 24 h (ii
and iii) followed by triple-labelling with antibodies specific for RTA and iHsp70 and Click-iT
EdU Alexa Fluor 647. Complete co-localisation between iHsp70, RTA and actively replicated
viral DNA (Edu-labelled) was observed in both incipient RTCs (ii) and in fully-developed
RTCs (iii). Note that in these cells iHsp70 was not depleted from the cytoplasm.
(TIF)
S2 Fig. Grp78 was not redistributed to KSHV RTCs during lytic replication in TREx
BCBL1-RTA cells. This finding is consistent with the ER retention signal found in Grp78.
(TIF)
S3 Fig. iHsp70 and Hsc70 formed nuclear foci in HEK-293T rKSHV.219 cells undergoing
lytic replication while Grp78 was not redistributed to RTCs. (A and B) Cells undergoing
lytic replication as identified by red fluorescent protein (RFP) expression displayed iHsp70 and
Hsc70 nuclear foci that appeared to assemble in RTCs. (C) The endoplasmic reticulum (ER)
Hsp70 isoform, named Grp78, remained in the ER regardless of lytic reactivation.
(TIF)
S4 Fig. Proliferation (MTS) assay in unreactivated TREx BCBL1-RTA cells exposed to
VER-155008 for 24 h. Cell metabolic activity was drastically reduced at 6.25 μMVER-155008.
(TIF)
S5 Fig. EGFP-RTA expression redistributed endogenous iHsp70 from the cytoplasm to the
nucleus.HEK-293T cells were transfected with control pEGFP or pRTA-EGFP for 24 h and
then analysed by immunofluorescence.
(TIF)
S6 Fig. ApoTox-Glo Triplex Assay in HEK-293T cells revealed that VER-155008 did not
increase cytotoxicity nor activate effector caspases. Cytotoxicity of VER-155008 was assessed
in cells exposed to increasing inhibitor concentrations for 24 h. Even at 60 μMVER-155008
there was no caspase 3/7 activation compared with DMSO control cells.
(TIF)
S7 Fig. Nuclear Hsc70 co-localised with viral DNA in KSHV RTCs. TREx BCBL1-RTA cells
were reactivated for 24 h in the presence of control DMSO (0.1%) or 2 μMVER-155008 fol-
lowed by labelling with Click-iT EdU Alexa Fluor 647 and an antibody specific for Hsc70. (A)
In DMSO-treated reactivated cells, Hsc70 formed multiple nuclear foci. Three cells showing
viral RTCs filled with viral DNA (Edu-labelled) which co-localised with Hsc70 foci can be
seen. (B) Cells treated with VER-155008 displayed Hsc70 protein distributed more equally
between the nucleus and cytoplasm and RTCs replicating viral DNA were not as abundant as
in DMSO-treated cells.
(TIF)
S8 Fig. Higher magnification of Fig 9Bii. VER-155008 at 2 μM abrogated RNAPII recruit-
ment to KSHV RTCs.
(TIF)
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S9 Fig. VER-155008 at 2 μM abrogated RNAPII recruitment to KSHV RTCs. TREx
BCBL1-RTA cells remained unreactivated or reactivated for 24 h in the presence of control
DMSO (0.1%) or 2 μMVER-155008 followed by labelling with Click-iT EdU Alexa Fluor 647
and an antibody specific for RNAPII (clone CTD4H8). (A) A high proportion of unreactivated
TREx BCBL1-RTA cells replicated their cellular DNA (Edu-labelled) in the presence of control
DMSO (0.1%) or 2 μMVER-155008. Normal RNAPII localization was observed in these cells,
with nuclear RNAPII excluding the nucleoli. (B) In contrast, reactivated cells entered cell cycle
arrest as demonstrated by fewer Edu-labelled cells. In the presence of DMSO, multiple RTCs
were formed with some replicating viral DNA (white arrows). In cells treated with VER-
155008, multiple pre-replicative sites were seen labelled by RNAPII antibody and Edu-labelling
was more diffused in the nucleus compared with DMSO-treated cells.
(TIF)
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